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This textbook is primarily intended for BSc students, but it is useful for 
everyone who seeks fast basic knowledge in the field of immunology. The 
information provided also makes the understanding of the “full-bodied”, 
advanced level immunology text books easier. The length of the text is kept 
limited and a significant part of it is constituted in the glossary, which contains 
the most important terms of the fields of biology and immunology. These terms 




The main function of the immune system is protection of the body against 
various pathogens, different biological toxins and even against altered, 
dangerous, abnormal cells inside the body. The two chief and clearly distinct 
functions of the immune system are recognition of the dangerous and/or 
pathogenic structures followed by the elimination/neutralization of these 
structures. 
What can be recognized by the immune system? 
Signs of biological danger  
Microbes differ significantly from the cells of our own body. These differences 
are manifested in their building materials, physical and chemical structure. 
Most of these are completely absent from our cells, while they are 
characteristic of various taxonomic groups of microbes or other pathogens 
(viruses, bacteria, uni- and multicellular parasites). Typical examples of these 
small conserved molecular motifs are double stranded RNA of some viruses, 
or lipopolysaccharides (LPS) found in the cell wall of the Gram-negative 
bacteria. These materials are collectively referred to as pathogen-associated 
molecular patterns, or PAMPs. The immune system can effectively sense the 
presence of these chemical structures with relatively few receptors called 
pattern-recognition receptors, PRRs, and interprets them as “danger”. 
Engagement of PRRs evokes strong activation signals. In addition to the above 
mentioned microbe-derived danger signals, injury or abnormal processes in the 
body may also act as danger signals resulting in the activation of PRRs. In the 
case of cell damage intracellular materials can appear in the extracellular space 
(outside of the cell). This presents a danger signal and alarms the immune 
system even in the absence of pathogens. These types of danger signaling 
molecules are called as damage-associated molecular patterns (DAMPs).  
The antigen 
The concept of antigen is easily understandable, yet antigen is one of the most 
ill-defined terms in immunology. As a general definition, the antigen is an 
entity recognized specifically by the B- and T-lymphocytes. The focus of this 
definition is on “specificity”. This presumes the presence of highly specific 
receptors that can bind to a given material or structure, but fail to recognize 
others. These extreme specificities have been demonstrated by experiments in 
which some small chemical modifications of an antigen can render an antigen 
unrecognizable by the receptor which had been recognized in its original form. 
Or it may work the other way around; after chemical modification the altered 
antigen can be recognized with high specificity by another receptor which, 
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before the modification, was unresponsive to it. Though in most cases small 
changes do not cause such a drastic effect in antigen recognition: modifications 
usually result in small changes in the binding affinity of the receptor to its 
specific antigen. The immune system can produce a vast variety of highly 
specific antigen receptors (in the order of billions). This receptor diversity is 
achieved by an elegant and sophisticated molecular genetic mechanism. An 
individual cell produces only one type of antigen-specific receptor, so one 
lymphocyte is specific to only one type of antigen. Based on these we can 
create a simple but seemingly circular definition: The antigen is an entity 
recognized by the antigen receptors. 
It is important to note, that not only pathogens can be considered as antigens. 
Antigen recognition could involve the recognition of the self-derived 
materials, but normally these don’t provoke a destructive immune response. 
The immune system is normally tolerant to self-antigens. According to the 
response following antigen recognition, we can classify immune responses into 
immunogenic and tolerogenic immune responses, and antigens into 
immunogenic and tolerogenic antigens (as discussed later). 
What terms should be used to describe immune recognition? 
Lipopolysaccharide, a bacterial cell wall component or a viral double stranded 
RNA should be considered as a PAMP, when it is recognized by pattern-
recognition receptors on various cell types. However, these structures are 
referred to as antigens when discussed from the point of view of lymphocytes 
that recognize them with their antigen-specific receptors, potentially capable 
of recognizing minor chemical or structural differences in PAMPs. Generally 
the first recognition of the pathogens and other danger signals are mediated by 
PRRs, and the fine recognition and distinctions between self, non-self or 
modified self-molecules are mediated by lymphocytes with antigen receptors. 
Destroying pathogens and tumour cells 
The elimination of the pathogens, infected cells and dangerous tumour cells 
can be mediated by only a few mechanisms. Defense mechanisms against 
extracellular and intracellular pathogens are based on distinctly different 
mechanisms. Extracellular pathogens can be directly attacked by the immune 
system while elimination of the intracellular pathogens is almost always 
mediated by killing of the infected cells. Elimination of tumour cells is similar 
to that of cells infected with intracellular pathogens.  
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The structure and organization of the immune system 
The cells of the immune system can be found almost everywhere throughout 
the body. Some of them operate “lonely” residing in various peripheral tissues. 
Immune cells can even be found in the epidermis. Others, together with several 
other immune cell types assemble into immune tissues with various levels of 
complexity. Lots of immune tissue ‘isles’ (follicles, folliculi) can be found in 
the mucosal membranes. At several places the immune tissues are organized 
into smaller or larger organs called lymphoid organs. The so called primary 
lymphoid organs are responsible for the production of the immune cells 
(interchangeably called ‘white blood cells’). The secondary lymphoid organs 
are sites where cells of the adaptive immune system (the B- and T-
lymphocytes) can first encounter the antigens. The secondary lymphoid organs 
provide an appropriate environment for the activation, proliferation, and 
differentiation of the lymphocytes.  
Primary lymphoid organs 
The red bone marrow is located in the spongy bone tissue of various bones. All 
the blood cells, so almost all white blood cells (leukocytes) including the 
lymphocytes of the immune system derive from the red bone marrow. The 
development of these cells starts from stem cells (hematopoietic stem cells). 
The stem cells in the red bone marrow initially differentiate into some 
specialized immune cell type in response to various/specific cytokines, and 
other chemical and local environmental stimuli. Two large developmental 
lineages can be defined: 
The myeloid lineage gives rise to the macrophages, dendritic cells, mast cells, 
and granulocytes. The other developmental pathway, the lymphoid lineage, 
provides the precursors of lymphocytes, which finally develop into B cells, T 




Figure 1. The development of immunocytes in the red bone marrow 
The cells of the immune system develop from the haematopoietic stem cell derived myeloid- 
and lymphoid precursor cells 
 
The red bone marrow and the thymus are the two primary lymphoid organs in 
the body as they are the sites of lymphocyte development. The progenitors of 
T-lymphocytes exit the bone marrow and enter the thymus where they 
complete their development. There is no active (immunogenic) immune 
response in the protected environment of the primary lymphoid organs. In 
healthy individuals pathogens are absent in the primary organs because this is 
a place where self-materials of the body (the self-antigens) are typically 
introduced to the developing lymphocytes. The cells of the adaptive arm of the 
immune system can meet the self-antigens here, and can ‘learn’ the antigens 
which should be considered as harmless, and thus, must be tolerated. Thanks 
to this ‘education’ the lymphocytes that leave the primary lymphoid organs 
will tolerate self-antigens present in both the primary lymphoid organs and the 
peripheral tissues of the body. You can find more information about these 
processes later in the ‘Immunological tolerance’ chapter. 
Secondary lymphoid organs and the lymphatic system: 
Secondary lymphoid organs are the activation sites of the adaptive arm of the 
immune response. Lymphocytes which successfully leave the primary 
lymphoid organs are called naïve lymphocytes, because they have not yet 
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encountered their specific antigen. naïve lymphocytes migrate into the 
secondary lymphoid organs, where they can meet and recognize microbial 
antigens. Antigen recognition induces activation of the naïve lymphocytes, 
which as a result, will proliferate and differentiate to become fully functional, 
‘effector’ lymphocytes. 
The blood transports nutrients and oxygen for the cells and tissues of the body. 
Some components of the blood plasma are filtered out from the capillaries into 
the tissues. This fluid, also known as lymph, contains various metabolic 
products of the tissue cells, or in case of an injury, microbes or other foreign 
materials from the environment. 
Lymph is collected by the lymphatic capillaries. Lymphatic capillaries are 
glove-like structures that originate in the tissues with closed ends and unite to 
form small lymphatic vessels, and later the lymphatic system. Foreign antigens 
are transported by the lymph into a nearby lymph node (also called as the 
draining lymph node) which provides a convenient checkpoint for monitoring 
antigen content of the lymph. The lymph filtered through the lymph node will 
enter into a larger lymphatic vessel. The small, bean shaped lymph nodes are 
distributed along the lymphatic vessels. They can form small groups in some 
parts of the body, the neck, armpits, groin or the abdomen, in particular. The 
continuously migrating cells of the immune system can gather in special, well 
defined compartments of the lymph nodes to encounter the accessible antigens, 




Figure 2. The scheme of the lymphatic system and the lymph node. 
The lymphatic circulation is a network of lymphatic capillaries, small and larger lymphatic 
vessels that collects and transvers lymph into the venal blood. Lymph enters the regional 
lymph node via the afferent lymphatic vessels. Lymph exits the lymph node via a single, large 
efferent lymphatic vessel and continues its journey further in the lymphatic system. The 
lymphocytes can encounter the antigens within the B- and T cell zones of the lymph node.  
 
The secondary lymphoid organs are the places where the lymphocytes meet 
their specific antigens the first time. If B- and T-lymphocytes “camping” in 
lymph nodes meet the antigen to which they possess a specific antigen 
receptor, they recognize it. After binding the antigen, provided other necessary 
activation signals are also received, they rapidly go through several cycles of 
cell division (proliferation). Thus, at the end of this process the number of 
antigen specific lymphocytes is increased many fold. The non-specific 
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lymphocytes, which fail to recognize any antigen will exit the secondary 
lymphoid organ sooner or later. They leave via the efferent lymphatic vessel, 
subsequently enter other secondary lymphoid organs/tissues and eventually, 
they will return into the blood circulation. They repeat these cycles until they 
find an appropriate antigen. If they fail to meet their specific antigen within a 
few days or for some cells for a few weeks they will die by apoptosis. 
Antigens not only enter the lymph nodes passively carried by the lymph. They 
can also be transported by phagocytic cells patrolling the tissues e.g. tissue 
macrophages and dendritic cells. These cells can engulf different antigens and 
actively transport them into the local lymph nodes using the lymphatic vessels. 
Once they have arrived at the lymph node they present the engulfed and 
processed antigens to the assembled T-lymphocytes. 
Lymphocytes can use both the lymphoid vessels and the blood vessels for 
traveling throughout the body. They generally enter the lymph nodes through 
the special kind of post-capillary veins called high endothelial venules, present 
in the lymph node. Lymphocytes exit the nodes through the efferent lymphatic 
vessel. They use the lymphatic system to travel back into the bloodstream. The 
lymphatic and the blood circulation is directly connected at the shoulder-neck 
region of the body. By the help of the left and right large main collecting 
lymphatic ducts the lymph, together with the travelling cells returns into the 
large veins. This way the lymphocytes can visit a large number of lymph nodes 
in all parts of the body in a relatively short time in order to find pathogen-
derived antigens.  
It is important to note that the naïve lymphocytes usually can’t get access to 
the tissues where the pathogens enter the body (skin, mucosa). But after their 
efficient activation in the secondary lymphoid organs, they become fully 
functional effector lymphocytes which can reach the peripheral tissues. 
The spleen is a long flat secondary lymphoid organ located at the upper left 
part of the abdomen. Similar to lymph nodes, the spleen has compartments, 
where the immune cells can communicate with each other, and can be 
activated. The spleen doesn’t have direct (afferent) connection with the 
lymphatic vessels, instead it functions as a filter of blood. The assembled 
lymphocytes in the spleen can encounter the antigens present in the blood. 
Lymphoid tissues (follicles) can be found at several locations in the body. 
Significant lymphoid tissues can be found in the wall of the digestive system 
and in the airways which are the main gateways of infection by various 
pathogens. Such lymphoid tissues are present in the tonsils and in the adenoid 
of the upper respiratory tract, in Peyer's patches found within the wall of the 
small intestine, or in the appendix of the coecum. 
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Multiple cell types may participate directly or indirectly in the immune 
response. In addition to cells various body fluids contain components essential 
to the coordinated operation of the immune system. Depending on whether the 
cellular or the soluble component plays a more prominent role in a particular 
response we call it a cellular- or humoral immune response, respectively. 
 
Primary lymphoid organs Secondary lymphoid organs 
 red bone marrow and 
thymus 
 production and initial 
differentiation of 
immunocytes 




 spleen, lymph nodes, the different skin-, 
gut-, respiratory tract associated lymphoid 
tissues 
 induction sites of the adaptive immune 
response (not exclusive, mainly connected 
with the adaptive immune response) 
 site of lymphocyte activation and 
differentiation of naïve lymphocyte into 
effector cells 
Properties and cells of the innate and adaptive immune 
responses 
The elements of innate immunity appear long before birth, and are 
constitutively present in the body. Its components are generated continuously, 
their production can only be increased moderately, even when they are needed. 
Thus, certain elements of the innate system can be exhausted. Nevertheless, 
innate immunity can provide an immediate response because its components 
are always present in the body. The innate immune responses are not antigen 
specific. It senses various „danger” signals released from microbes or by 
damaged tissues. During an immune response the number of innate immune 
cells shows only moderate changes. Though infections can induce a small 
increase in cell numbers, rather the localization and activation state of the cells 
will be changed. 
Cells of the innate immune system are constantly renewing to replace old dying 
cells ensuring continuous responsiveness of the system. The typical cellular 
elements of the innate immunity are granulocytes, dendritic cells, 
monocytes/macrophages and NK (natural killer) cells. Its humoral components 
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include the complement system (described later), antimicrobial proteins, 
enzymes or peptides. 
It has been observed centuries ago that people who survived the ravages of an 
epidemic were untouched when faced with that same disease again – they had 
become immune to infection. The reason for this is that during the first 
(primary) immune response in addition to activated effector B and T cells 
memory B and T cells are also formed. During the subsequent exposure to the 
same pathogen, thanks to the presence of long-lived antigen specific memory 
cells, the immune system is ready to launch a faster, more intensive and thus 
much more effective immune response. This kind of antigen specific immune 
response – characterized by memory and improved response upon second 
exposure - is called acquired or adaptive immune response.  
Active adaptive immunity is not yet present in the newborn. However, the 
adaptive immune system continuously produces new lymphocytes with diverse 
antigen specificity. Only a few of these (naïve) lymphocytes are able to 
recognize a particular pathogen, therefore, only a small number of 
lymphocytes are available to respond to any given pathogen. When an antigen 
enters the body, only a few cells will respond, but they will divide intensively 
to produce a large number of effector cells which can successfully fight even 
the fast-growing microbes. The immune system shapes its response according 
to its actual challenges. The number of effector cells gradually decreases after 
they have completed their functions, however, some long-lived memory cells 
will survive, providing protection should the same pathogen be detected again. 
Activation, proliferation and differentiation of lymphocytes take time, 
therefore, relatively longer time (about one or two weeks) is necessary to 
achieve the maximal response following exposure to an antigen. However the 
immune system can react more quickly the next time it comes into contact with 
the same antigen because of the presence of memory cells that have gone 
through an initial proliferation and differentiation process. Only a few days (3-
5 days) is sufficient to boost the immune response again.  
The cellular components of the adaptive immunity are T and B cells bearing 
antigen-specific receptors. Its humoral elements include immunoglobulins or 
antibodies produced by plasma cells that differentiate from B cells. Antibodies 
can be found almost everywhere in our body.  
The immune system consists of a wide range of different cell types including 
lymphocytes and also various types of phagocytes. The cells of innate 
immunity are able to fight different kinds of invading pathogens while a given 
cell of adaptive immunity is designed to recognize only one specific target by 
its antigen-specific receptor with high efficiency. For an effective response the 
 15 
immune cells need to communicate with each other. Sometimes a direct cell-
cell contact among the immune cells is required, while at other times cells use 
soluble messenger molecules for communication. The freshly generated, so-
called „naïve" lymphocytes – which have not encountered their antigens yet – 
are unable to function without previous interaction with other immune cells. In 
this case they may become functionally unresponsive after antigen exposure. 
This state of the cells is referred to as anergy.  
The components of innate immunity are essential for the activation of adaptive 
immunity, in return some elements of the adaptive immunity can facilitate 
some of the functions of natural/innate immunity. Thus, the two systems work 
in concert supporting each other’s functions.  
 Innate Immunity Adaptive Immunity 
properties 
 immediate reaction 
 not antigen specific 
 no memory 
 requires several days to 
develop  
 antigen-specific 










Phagocytes and other cells of innate immunity 
The cells of the innate immune system include phagocytic cells such as 
monocytes/macrophages and the dendritic cells. These large cells are able to 
engulf, kill and digest microbes, but they are also involved in the phagocytosis 
of other materials, for example dead cells or cell debris. In the case of these 
cells phagocytosis is not only the function of the elimination of the engulfed 
material. The processing and „presentation” of pathogen-derived ingested 
materials to lymphocytes plays an important role in the activation of the 
adaptive immune response.  
The following section provides an overview of innate immune cells: 
 
 16 
Monocytes which circulate in the blood are the precursors 
of phagocytes. After entering the tissues they differentiate 
into macrophages or into dendritic cells. Specialized 
macrophages found in various tissues and organs often have 
different names. For example, macrophages are referred to 
as microglia in the central nervous system, Kupffer cells in 
the liver, osteoclast in the bones, alveolar macrophages in 
the lung and histiocytes in connective tissues. 
 
The macrophages are perhaps the most ancient cells of the 
immune system, with numerous functions. 
 During bacterial infections macrophages are one 
of the first cell types which recognize the pathogen.  
 After detection of pathogens they may be able to 
destroy them alone.  
 Upon activation, macrophages secrete messenger molecules 
(cytokines) which induce local inflammation and recruit other immune 
cells to the site of infection. 
 As professional antigen-presenting cells (APC), macrophages 
participate in the induction of the adaptive immune response.  
 In addition to engulfing and elimination of foreign antigens, dead cells 
or tissue debris of various sizes, macrophages also play an important 
role in the regeneration of damaged tissues, mainly by the secretion of 
growth factors.  
The name macrophage – as discussed above – does not necessarily refer to a 
specific cell type, rather it is a collective name of cells with similar functions. 
The functions listed above are often divided among the different subtypes of 
the macrophages. 
 
Granulocytes with typical morphological properties are the 
effector cells of innate immunity against bacteria and some 
eukaryotic parasites. Their cytoplasm contains a large 
number of preformed granules with powerful antimicrobial 
substances for the elimination of parasites or microbes. 
Neutrophil granulocytes are the most abundant members of the granulocyte 
family that also represent the most abundant population of circulating white 
 17 
blood cells in the human body. These phagocytes are real „kamikaze cells” 
specialized only for the destruction of bacteria/pathogens. In healthy 
individuals neutrophils circulate in the blood stream and they are absent from 
healthy but not from inflamed tissues. In the case of an injury or pathogen 
exposure, a large number of neutrophil granulocytes migrate quickly from the 
blood to the sites of infection following chemical signals such as cytokines and 
chemokines produced by danger signal-sensing cells (e.g. macrophages). At 
the site of infection they engulf the bacteria or release the substances stored in 
their granules to eliminate the pathogens. Subsequently, neutrophils die by 
programmed cell death in a short time capturing the bacteria in their own 
apoptotic bodies. Later, the dead cells and other cell debris are cleaned up by 
macrophages.  
The main functions of eosinophil and basophil granulocytes are similar to 
that of mast cells to be discussed later in this section. By special toxic 
substances stored in their granules they provide protection against unicellular 
and multicellular eukaryotic parasites that are too large to be taken up by 
phagocytosis. Eosinophils and basophils also play a pivotal role in the 
development of allergic reactions (described later). 
 
Dendritic cells were named based on their branch-like 
projections, similar to the dendrites of neurons. Like 
macrophages, they also have various subtypes in 
different tissues and organs. During infection, as most 
innate cells, dendritic cells detect the pathogens 
immediately. However, the main function of dendritic 
cells is not the direct elimination of pathogens, rather 
to deliver pathogen-derived antigens into the lymph 
nodes and present them to various types of T cells. Because of this activity they 
are called professional antigen-presenting cells. Immature dendritic cells 
localize in the peripheral tissues mainly at the sites of pathogen entry (skin, 
gut, and lung). In these tissues their functions are the immediate recognition 
and uptake of pathogens. Activation by the recognition of harmful microbes 
induce characteristic changes in dendritic cells. They start to migrate into the 
draining lymph nodes through lymphatic vessels and they increase the 
expression of cell surface molecules essential for the activation of other 
immune cells. In the lymph nodes dendritic cells present the antigen in 
complex with MHC molecules for T cells (a more detailed description of the 
process will be provided in later sections). It is important to note that as the 
most effective professional antigen-presenting cells, dendritic cells are able to 
activate „naïve” T cells freshly released from the thymus. 
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The natural killer cells (NK cells) are a special class of 
lymphocytes. Similar to cytotoxic T cells they take part in 
the elimination of infected or malignant cells of the host. 
They store pre-formed toxic substances in their granules. 
They destroy the target cells by releasing the substances of 
these granules or by direct cell-cell interaction. In addition 
to the recognition of pathogen-associated molecular patterns and opsonins 
(described later), NK cells are specialized for sensing of typical stress-induced 
molecules on the surface of infected or tumour cells. However, the healthy host 
cells block the function of NK cells through inhibitory NK-cell receptors. Cells 
bearing „normal” self-markers are not attacked by NK cells. Furthermore NK 
cells are very aggressive toward cells that are missing „normal” self-markers. 
Overall, the activation of NK cells is regulated by the balance of inhibitory and 
activating signals. (a more detailed description of the process will be provided 
in later sections). 
 
Mast cells provide protective immune responses against 
parasites. Mast cells unlike the functionally similar 
basophil granulocytes, are localized in various tissues, 
e.g. in the skin or in the wall of the bronchoalveolar or 
gastrointestinal tracts. The mediators of these cells 
released from their granules are responsible for the 
symptoms of allergic reactions; however, these mediators 
had originally evolved for the elimination of multicellular parasites. 
 
Platelets (thrombocytes) are blood circulating fragments derived from 
megakaryocytes, their large precursor cells present in the bone marrow. They 
also contain granules in their cytoplasm. Platelets play a role in the formation 
of thrombus during coagulation. When activated, they gather to form 
aggregates at the site of injured endothelium and then release substances of 
their granules containing coagulation factors, growth factors acting on various 





 Macrophages  
 Dendritic cells 
 Neutrophil granulocytes  
 Macrophages  
 Dendritic cells 
 B-lymphocytes  
Cells of the adaptive (acquired) immunity 
The cells of adaptive immunity are the B- and T-lymphocytes (or also called B 
and T cells). These cells carry a unique receptor specialized for the recognition 
of only one type of antigen. Although the individual cells are able to recognize 
only one antigen, the billions of B and T cells together can detect billions of 
different structures. 
B cells recognize the antigens by their cell surface antigen 
receptors. The antigen receptor of the B cell is a cell surface 
immunoglobulin. B cells express numerous membrane-
bound cell surface immunoglobulins, so one antigen can be 
bound by more receptors at the same time. Following 
detection of antigens B cells get activated and differentiate 
into plasma cells. Plasma cells, the terminally differentiated form of B cells do 
not carry cell surface immunoglobulins, but they produce large amounts of 
these proteins in a soluble form which are commonly known as antibodies. 
Secreted immunoglobulins enter the surrounding tissue fluids and blood 
circulation. Secreted immunoglobulins or antibodies recognize the antigens of 
various pathogens and bind to them to mark (called opsonization) or to 
inactivate them (called neutralization). 
Two main types of T cells are distinguished. The cytotoxic 
T cells specialized in the killing of infected or tumour cells 
and the helper T cells which play an important role in the 
facilitation and regulation of the immune responses. Helper 
T cells can enhance cytotoxic T cell responses, help 
macrophages to destroy the engulfed microbes and support 
antibody production of B cells. The two cell types can be 
easily distinguished based on their cell surface molecules. Cytotoxic T cells 
express CD8 while helper T cells express CD4 cell surface receptors. Briefly, 
they are CD8+ (CD8-positive) or CD4+ (CD4-positive) cells. 
As has been repeatedly mentioned, please note that freshly generated so-called 
„naïve” T and B lymphocytes derived from the primary lymphoid organs are 
not fully functional! Further maturation/activation processes in the secondary 
 20 
lymphoid organs or tissues are required for „naïve” lymphocytes to 
differentiate into functional effector cells. 
Communication between immunocytes: cytokines and cell surface 
molecules 
Immune cells communicate with each other in several ways. (Figure 3.) 
 By cell surface molecules and receptors through direct cell-cell 
interaction. (The most important cell surface molecules are discussed 
in the appropriate chapters.) 
 By soluble molecules, which play a pivotal role in the communication 
of immune cells. These chemical messengers can be different peptides, 
proteins, glycoproteins, which are collectively called cytokines. 
 
Figure 3. Communication in the immune system. 
Cells of the immune system exchange information with each other through direct cell-cell 
contact or through soluble factors, primarily via secreted cytokines which are sensed by 
cytokine-specific receptors on the target cells. (Each cell can express a large number of different 
receptors. The number of cell surface cytokine receptors expressed by a given cell may vary 
considerably, reaching up to millions/ cell. In the figures of this lecture notes neither the number- 
nor the size of receptors are not presented on scale.) 
 21 
Cytokines are hormone-like substances which are effective at very low 
concentration. Secreted cytokines can act in an autocrine manner on the cell 
that produced them or they can act locally on other cells in a paracrine manner. 
However, some cytokines can also have endocrine effects by influencing the 
function of distant cells or organs.  
Responsiveness of a cells to a given cytokine is determined by the expression 
of the cell surface receptor specific to that particular cytokine. A single cell 
expresses various cytokine receptors so a given cell is usually affected by 
multiple cytokines which could modify (enhancing or inhibiting) each other’s 
effect. Of course, a particular cytokine can affect the functions of many 
different cell types and can induce different responses in different types of 
cells. The functions of each cell will be influenced by the combined effects of 
the parallel signals (cytokines, other receptor signals, cell-cell interactions). 
Cytokines are classified in many ways, and these groups often overlap with 
each other. For example, some cytokines belong to both the group of 
lymphokines and the group of monokines as they are produced by both 
lymphocytes and monocytes. 
Cytokines involved in the communication between white blood cells 
(leukocytes) are often referred to as interleukins. Interleukins are distinguished 
from each other by numbers. To date, more than 30 kinds of interleukins have 
been described. One of them is interleukin-2 (IL-2) which induces the 
generation and cell division of T cells. Other cytokines regulate the activation 
and differentiation of leukocytes (e.g. IL-12, IL-4, IL-10). The so-called pro-
inflammatory cytokines including for example TNF, IL-12 or IL-6, have 
pivotal roles during inflammatory processes. 
There are some cytokines which can act as growth factors influencing 
maturation and differentiation of various cell types of the immune system. For 
example, the granulocyte-macrophage colony-stimulating factor (GM-CSF) 
induces the production of granulocytes and monocytes in the bone marrow. 
Cytokines inhibiting (interfering with) viral infection are classified as a 
separate group called interferons. 
Chemokines are cytokines that induce chemotaxis, attracting the appropriate 
chemokine receptor bearing cells towards the source of the chemokine. Such 
mediators facilitate for example the migration of blood-circulating 
lymphocytes and tissue-localized dendritic cells towards the lymph nodes. 
Large amounts of chemokines (e.g. CXCL8) and chemotactic factors (e.g. 
cleavage products of complement proteins) are produced in the infected or 
inflamed tissues which recruit neutrophil granulocytes, monocytes among 
other cells to the site of inflammation. 
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The innate immune system 
The innate (or natural) immune cells are the monocytes/macrophages, the 
dendritic cells, the granulocytes and the NK cells. Humoral components of 
innate immunity include antimicrobial substances produced not only by 
immune cells: enzymes, antimicrobial peptides (e.g. defensins) can be 
produced by the liver or the epithelia. The proteins of the complement system 
and their cleaved fragments play a particularly important role.  
The ancient mechanisms of innate immunity provide an immediate response. 
The most important phases of the response: 
 detection of pathogen or danger signal,  
 alarming and mobilization of other elements of immune system 
(including both the innate and the adaptive components), 
 elimination of the pathogen as soon as possible. 
Recognition of pathogens by the innate immune system: danger 
signal sensing receptors, pattern recognition, opsonins 
The overall structure as well as composition of macromolecules present on the 
surface of microorganisms differ significantly from those found in higher order 
organisms. The „aim” of the innate immune cells is to detect characteristic 
danger signals and/or molecular structures present in microbial pathogens, but 
absent from human cells. These molecules are recognized by immune cells 
either in their soluble form or bound to the surface of a pathogen. For example 
the essential cell wall components of different bacteria (e.g. polysaccharides, 
peptidoglycans and lipopolysaccharides) or flagellin induce strong activation 
signals in phagocytes. Similarly, double-stranded RNA present in some viruses 
represents a danger signal for various cell types. These molecules indicating 
the presence of pathogens are called pathogen-associated molecular patterns 
(PAMP). Their presence is clearly a sign of danger, so their appearance has to 
be monitored by various types of pattern recognition receptors (PRR) 
expressed on different immune cells. The pattern recognition receptors 
appeared early on during evolution. They are expressed by all multicellular 
organisms from simple worms to the most sophisticated plants. PRRs are 
evolutionarily conserved structures as they recognize similarly conserved 
target molecules of pathogens. 
The function of PRRs is not restricted to the recognition of extracellular 
pathogens. Intracellular pathogens living in the cytosol or in the vesicular 
system need to be recognized by immunocytes, thus some PRRs need to be 
localized in these compartments. Some of these receptors can readily bind to 
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particles in the endosomal compartment, another set of the receptors sense the 
pathogens in the cytoplasm. In addition to many immune cells, epithelial cells 
localized in various surfaces of the human body can also express pattern 
recognition receptors. Almost all types of these receptors are expressed on 
different macrophages and dendritic cells. (Figure 4.) 
Sometimes self-derived molecules released by necrotic cell death or tissue 
damage called danger- or damage-associated molecular patterns (DAMP) can 
also serve as danger signals. This involves the “free” form of the genomic DNA 
itself, which is enclosed into the nucleus under normal circumstances. Its 
appearance in the cytoplasm may suggest that cells were infected by a DNA 
virus, or its extracellular localization may indicate damage-induced necrotic 
cell death which is an alarm signal for the immune system. Many other 
substances originally derived from nucleus or cytosol (e.g. extracellular ATP) 
are recognized extracellularly as DAMP by the immune system.  
The recognition of pathogens and/or danger signals by the immune system is 
mediated by a group of a few dozen receptors only. These receptors are able to 
identify essential and conserved structures characteristic of various pathogen 
groups. Thus, innate immune cells can detect practically all pathogens by using 
these few pattern recognition receptors. However the recognition is not specific 
to each pathogen species, because specific (individual) recognition of tens of 
thousands of pathogens is impossible by only a few types of receptors. These 
receptors, however, provide sufficient information about the type of the 
infecting agent, about the site of the infection and about the type and 
localization (intra- or extracellular) of the pathogen allowing the induction of 
an appropriate anti-microbial immune response. 
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Figure 4. Detection of the pathogens by pattern recognition receptors. 
The pattern recognition receptors of the innate immune system recognize structures that are 
characteristic of pathogens but not of human cells (e.g. bacterial cell wall components, double-
stranded viral RNA). The pattern recognition receptors localize either on cell surface or inside 
the cells allowing the recognition of both extracellular and intracellular pathogens. They do 
not distinguish between individual species of microbes, they rather indicate the appearance of 
pathogens in the body. 
Although innate immune cells are capable of recognizing pathogens in itself, 
the response is accelerated and enhanced in the presence of opsonins. Opsonins 
produced by the human body bind to pathogens to mark or target them for 
destruction. Opsonization facilitates the recognition and phagocytosis of 
pathogens by the innate immune cells. In addition to many cell surface 
receptors detecting pathogens directly, there are different opsonin receptors 
specialized for the recognition of opsonins bound to the surface of pathogens. 
The opsonin is forming a bridge between the pathogen and the opsonin 
receptor of the phagocytic cell (e.g. Fc receptors or complement receptors). 
Various molecules can act as opsonin during the immune response. Such 
molecules include antibodies, some complement fragments and the so-called 
acute phase proteins synthesized by the liver in response to pro-inflammatory 
cytokines. (Figure 5.). 
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Figure 5. Opsonization and pathogen recognition 
Opsonization facilitates detection and accelerates phagocytosis of pathogens. The phagocytes 
can recognize the microbes by pattern recognition receptors. If the pathogen is coated by 
opsonins, the opsonin receptors are sufficient for the indirect detection of pathogens. 
Elimination of pathogens by the innate immune system 
The extremely fast reproduction rate of pathogens far exceeds that of the 
human populations. The number of some bacteria can increase by a hundred 
fold within a few hours in ideal circumstances. Therefore, both the immediate 
recognition and the early elimination of the invaders are crucial for protecting 
the host. The innate immune system represents the first line of defence. It is 
responsible both for the quick recognition and the rapid elimination of the 
pathogens. In lots of cases a few simple mechanisms can ensure the effective 
eradication of the highly variable pathogens: 
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 Phagocytic cells, mainly macrophages and neutrophil granulocytes 
engulf the pathogens and subsequently kill them, even at the cost of the 
death of the phagocytes themselves.  
 Granulocytes and macrophages secrete toxic mediators to kill 
microbes, including reactive oxygen species, nitric oxide, or different 
degrading enzymes. Multicellular parasites are relatively complex 
organisms, often protected by capsule. Mast cells, basophil- and 
eosinophil granulocytes are specialized to eliminate these parasites 
with their specific destructive enzymes. 
 Activation of the complement system may cause the direct lysis of 
some pathogens. Alternatively, complement fragments act as opsonins. 
 The elimination of intracellular pathogens requires a different strategy. 
In this case, microbes are not attacked directly, the infected human cells 
need to be killed instead. Among the cells of innate immune system, 
NK cells are capable of rapid killing of the infected cells. (Beside NK 
cell, the cytotoxic T cells, as part of the adaptive immunity play a major 
role in this process, as we will discuss it later.) 
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Figure 6. The elimination of microbes by the cells of innate immune system 
Following pathogen recognition, phagocytic cells engulf, kill and intracellularly digest the 
microbes. Granulocytes and macrophages secrete toxic mediators. Complement components 
lyse pathogens by binding to their surface. NK cells kill infected cells in order to eliminate 
intracellular pathogens. 
The alarm system of the body: the acute inflammation  
Interactions among few cells can be sufficient to initiate the immune response. 
Macrophages and dendritic cells play a critical role in this process. These two 
cell types are present all over in the human body, especially around the external 
and internal surfaces, where pathogens can enter into the tissues. Besides 
dendritic cells and macrophages, the cells of the epithelia also contribute to the 
alarming process. These few cell types express the entire panel of pattern 
recognition receptors. However, their effector functions are markedly different 
following the recognition of pathogens. The primary role of dendritic cells is 
not the elimination of the pathogens, but to transport the antigens to the lymph 
nodes, to present them for T lymphocytes, and thus, alarm and activate the 
adaptive immune system. Macrophages on the other hand initiate effector 
functions straight away for immediate elimination of the pathogens. Small 
number of pathogens can be eliminated by macrophages lining around the 
pathogens’ entry site. When a large number of pathogens enter our body 
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macrophages alone cannot cope with the infection. Upon activation of their 
pathogen or opsonin sensors they alarm other actors of the innate immune 
system, and recruit them into the site of infection by initiating local 
inflammation (Figure 7). The extremely fast proliferation of pathogens 
demands instant responses. The innate immune system delivers an immediate 
immune response, so it plays the main role in the rapid and short-lived (acute) 
inflammation. In addition to this „gate-keeper” function dendritic cells and 
macrophages are capable and necessary in the activation of the adaptive 
immune response. Local inflammation developing around the entry site of 
pathogens is absolutely necessary in immune defense against microbes. The 
recognition of incoming pathogens by opsonin- or pattern recognition 
receptors, activates macrophages resulting in the production of hormone like 
molecules –cytokines and chemokines- which recruit and activate other 
immune cells. Epithelial cells and mast cells are also able to initiate similar 
alarm mechanisms. 
The volume of circulating blood increases in inflamed tissues due to 
vasodilation (an increase in the diameter of the vessels) and in the meantime, 
vessels become permeable (leaky). The chemokines and cytokines produced 
by macrophages also activate the cells of the vessel walls, the endothelial layer. 
As a result, the expression of several adhesion molecules are induced on the 
surface of the endothelial cells around the infected area. Secreted cytokines 
also assist the extravasation when phagocytes, such as granulocytes, 
monocytes and other cells (e.g. NK cells) migrate into the site of inflammation. 
Leaky vessels will allow diffusion of more and more humoral factors, 
including those of the complement system and even antibody molecules from 
the blood to the infected tissue. Some cytokine-like mediators lower the 
sensory-threshold of the nociceptors. As a result, a painful swelling, so-called 
oedema develops at the site of infection. Reactions in the inflamed tissue 
increase the intensity of lymph flow and thus facilitate the transport of antigens 
towards the surrounding lymph nodes initiating the activation of antigen 
specific lymphocytes. 
The clotting system is also activated to cope with the collateral damage of the 
blood vessels and possibly to isolate the pathogens or at least slow down their 
spreading. The last phase of inflammation is tissue regeneration. During this 
process, special cytokines acting as growth factors potentiate the proliferation 
of fibroblasts and/or the process of angiogenesis. 
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Figure 7. Acute inflammation 
At the site of infection macrophages recognize the pathogens and subsequently produce 
inflammatory cytokines, inducing vasodilation and increased vascular permeability. 
Granulocytes, Monocytes, NK cells, complement components can exit from the circulation at 
these sites and eliminate the pathogens in the infected tissues. 
Inflammatory cytokines (especially TNF, IL-1, IL-6) are produced by the 
activated cells, chiefly by macrophages. These cytokines are important at the 
site of inflammation, however they also have endocrine effects, acting 
throughout the entire human body: 
 Induction of fever by acting on the hypothalamus, 
 Increased production of acute phase proteins and antimicrobial 
molecules by the liver.  
 Enhanced production of leukocytes in the bone marrow, to replenish 
cells lost during the immune reactions 
 
Various mechanisms of the innate and adaptive immune response create the 
anti-viral immune response. Besides cellular components, Type I interferons 
play a critical role in innate anti-viral immune responses. Almost all kinds of 
cells, (not only the cells of the immune system) are able to produce these 
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cytokines upon viral infection. Infected cells secrete interferons following 
recognition of viruses by their pattern recognition receptors. Interferons 
transmit autocrine and paracrine effects, inducing anti-viral state inside the 
cells, which block the propagation of the viral replication by blocking protein 
synthesis or activating the degradation of viral RNA. 
The function of the complement system  
The complement system itself is able to recognize and eliminate many 
pathogens and in the meantime alert further components of the immune 
system. It consists of around 30 proteins. Cooperative actions of these proteins 
assist and complement the function of antibody molecules. Most of the 
complement proteins are present in the blood plasma as inactive proenzymes. 
Activation of the first element leads to the activation of the proteolytic cascade 
system by a domino effect. Activated complement components process 
subsequent proteins of the cascade by limited proteolysis resulting in the 
activation of the next component. The different complement components are 
cleaved in a regulated, determined sequence. Before the inactivation of an 
activated complement factor (enzyme), multiple copies of the next member of 
the proteolytic cascade are usually cleaved, which leads to the amplification of 
the signal. 
The surface of pathogens is able to activate the complement system (either 
directly or mediated by the opsonization by antibodies). Certain types of 
antibody molecules, related to the adaptive arm of the immune system, are 
highly effective opsonins initiating the complement activation. 
Several specialized inhibitors block spontaneous, pathogen independent 
activation of the complement system in the human body. Some of these 
inhibitors are expressed constitutively in the human serum while others on the 
surface of cells. The absence of complement inhibitors on the pathogens may 
result in complement activation without the specific recognition of pathogens. 
The main effector functions of the complement system: 
 Mark different microbes (opsonization) and thus help the phagocytic 
cells of the innate immune system to recognize, engulf and destroy 
opsonized pathogens. In addition, complement factors can bind to 
antibody molecules attached to the pathogen surface (antigen-antibody 
complexes or immune complexes), consequently further facilitate 
phagocytosis. 
 Complement driven opsonization is necessary for efficient removal of 
soluble immune complexes from the human body (discussed later). 
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 Following activation, the last elements of the complement cascade 
creates a pore across the bacterial or cellular membrane. This process 
leads to the loss of the transmembrane ion balance, which finally 
results in the death of the attacked cells. 
 Some of the activated complement components function as a 
chemotactic factor and recruit different cells of the immune system to 
the site of complement activation. These complement components – 
sometimes called as anaphylatoxins – contribute to the process of 
inflammation by enhancing vasodilation and increasing the 
permeability of blood vessels. 
MHC molecules, antigen presentation 
T cells and B cells recognize antigens in a very different way. T cells cannot 
see the antigen in its native form, only the fragments of the antigens after 
partial degradation and processing. 
Most of the T cells recognize peptide fragments of protein 
antigens. Small peptides in their native form cannot 
achieve stable organised conformation. Peptides are 
therefore displayed by cell surface molecules of the host 
cells which stabilize the structure of peptides by limiting 
conformational changes. 
These ’peptide display molecules’ are called MHC (Major Histocompatibility 
Complex) proteins, and cells that express them are called antigen-presenting 
cells. Thus, the main task of the MHC molecules on the surface of an antigen 
presenting cell is to present peptides derived from various proteins to T cells. 
The antigen-specific receptors of T cells recognize the complex of a peptide 
displayed by an appropriate MHC molecule. (Figure 8) 
Figure 8. Antigen presentation 
T cells recognize peptides in complex with MHC 
molecules on the surface of antigen presenting cells. The 
peptide and the MHC molecule, as a complex, is 
recognized simultaneously by the T cell receptor. 
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The MHC molecules 
The MHC molecules (in human also called HLAs – Human Leukocyte 
Antigens), are encoded in the Major Histocompatibility Complex gene region. 
The MHC gene region encodes most of the proteins that are involved in the 
process of antigen presentation. 
This region contains the most polymorphic genes (with the highest number of 
allelic variations). As a result these genes encode proteins with the greatest 
diversity in the human population. Thus, most individuals of the population 
possess MHC molecules with slightly different structures but these molecules 
have identical function. The different MHC molecules encoded by different 
alleles can be recognised as “foreign” when some tissue or organ is 
transplanted into an other person, and the immune system will attack, reject 
the transpklant. This is why the name of this gene region refers to 
histocompatibility. 
On the cell surface, a vast number – even millions – of MHC molecules can be 
found simultaneously. One MHC molecule has affinity to various peptide 
sequences, but one MHC molecule binds only one peptide. All the MHC 
molecules on a cell surface together are able to present many different peptides 
from various different proteins at the same time to the T cells. 
Under normal circumstances only common self-protein derived peptides are 
presented by the help of MHC molecules. However, in the case of an infection 
microbial peptides can also appear on the cell surface presented by several 
MHC molecules among the normal self-peptide presenting ones. Tumour cell-
specific peptide fragments (from altered proteins) can be also presented among 
the normal self-peptides this way. 
By checking tens of thousands of different peptides bound to MHC molecules 
on the surface of the antigen presenting cell, T cells are able to find a few 
specific MHC-peptide complexes, which activate them. 
MHC I and MHC II 
Two main types of antigen presenting molecules exist. Almost all cells of the 
body express MHC class I molecules (red blood cells can be mentioned as an 
exception). MHC I molecules bind peptides derived from proteins which are 
sliced in the cytosol. This is called as endogenous antigen presentation. Either 
the self-proteins of the cell or the proteins of intracellular bacteria, viruses or 
the abnormal proteins of the tumour cells can be presented this way to CD8+ 
cytotoxic T cells. 
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MHC class II molecules show a much more restricted pattern of expression, 
being expressed mainly on the surface of the so-called professional antigen 
presenting cells. Using MHC II molecules, macrophages and dendritic cells 
present extracellular (exogenous) peptides derived from antigens engulfed 
from the extracellular space. Self-peptides of the body or foreign microbial 
peptides can be presented in complex with MHC II molecules, which can be 
recognized by CD4+ helper T cells. 
Thus cytotoxic T cells and helper T cells recognize antigens presented by 
different types of MHC molecules and the peptides presented by this different 
type of MHC molecules are derived from different cellular or tissue 
compartments. 
Antigen presentation 
Based on what we have learned so far, antigen presentation seems to affect the 
function of T cells only. In fact, during antigen presentation significant changes 
occur in the antigen presenting cells as well. The antigen presenting cell and 
the T cell mutually affect each other. 
MHC I 
With some exceptions (e.g. red blood cells) MHC I molecules are expressed 
on all human cells. They display mainly endogenous peptides on the cell 
surface for CD8+ cytotoxic effector T cells (Figure 9). Through the presented 
peptides, T cells can monitor what kinds of proteins are present inside the cells. 
Due to this process T cells could theoretically detect any intracellular 
pathogens, thus, antigen presentation by MHC I renders the intracellular space 
a subject for immunological 
monitoring or immunosurveillance. 
The antigen presentation process is 
Figure 9. Presentation of intracellular 
pathogens on MHC I  
MHC I molecules display peptide fragments 
which derive from proteins degraded in the 
cytoplasm. In case of an infection microbial 
peptides derived from intracellular 
pathogens are (also) bound to MHC I. 
Cytotoxic T cells recognize the MHC-I – 
peptide complex and may kill the infected 
antigen presenting cell. 
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not selective. It presents peptides from any protein located in the cytosol  
(self/non-self), regardless whether it is derived from a pathogen or not. MHC 
I molecules can present peptides of the cell’s own proteins, but they can display 
peptides derived from intracellular bacteria or in case of a viral infection viral 
peptides can be also displayed. Based on the displayed peptides the T cells will 
decide whether there is any dangerous modification or infection of the antigen 
presenting cell. 
MHC I bound peptides are generated in the cytoplasm (cytosol). The large 
multi-subunit housekeeping enzyme complex called the proteasome cleaves 
proteins into peptide fragments of the correct size to allow complex formation 
with MHC I. The degradation of proteins in the cell is a natural process, as all 
kinds of cellular proteins are degraded by proteasomes. The generated peptides 
are delivered into the endoplasmic reticulum (ER) by a transporter protein 
complex. In the ER the freshly synthesized MHC molecules stabilised in 
peptide receptive conformation by chaperon proteins, so the transported 
peptides can bind to them. Usually 8-10 amino acids long peptides bind to the 
peptide-binding groove of MHC I molecules. Once an appropriate peptide has 
been bound to MHC I in the ER and the chaperons are dissociated, a 
conformational change occurs. The MHC molecule becomes „closed”, unable 
to exchange the bound peptide. 
In this peptide-bound state, the MHC I molecules can leave the endoplasmic 
reticulum and pass through the Golgi-apparatus, finally they appear on the cell 
surface. Under normal circumstances „empty” MHC I molecules, without a 
bound peptide, cannot be found on the cell surface. 
The significance of this strict process is to prevent the binding of extracellular 
peptides to MHC I molecules on the cell surface, otherwise healthy cells near 
the site of infection could become the targets of cytotoxic effector cells.  
When the CD8+ cytotoxic T cells recognize peptides of foreign or harmful 
cellular proteins in complex with MHC I molecules, they kill the target cell to 
prevent further spreading of the infection or the development of a tumour. MHC 
I is expressed on the surface of all nucleated cells, so if any cell becomes infected, 
following antigen presentation, they become a target for cytotoxic effector T cells. 
In contrast to cytotoxic T cells, natural killer cells (NK cells) isn’t activated by 
MHC I bound peptides, but rather the lack of MHC I molecules, which unleash 
their activation.  
This mechanism can be effective in killing those cells, which lack MHC I 
molecules avoiding recognition by the adaptive immune system. For example 
certain virus-infected cells express only a very limited number of MHC 
 35 
molecules, thus they become „invisible” to cytotoxic T cells. However NK 
cells detect the lack of MHC I and destroy the abnormal cells. 
MHC II 
The MHC II molecules are expressed by the professional antigen presenting 
cells such as dendritic cells, macrophages and B cells. These cells are able to 
engulf extracellular antigens and to present them on MHC II molecules to 
CD4+ helper T cells. MHC II molecules (unlike MHC I) are specialized to 
display antigens derived mainly from exogenous origin (Figure 10). 
 
Following phagocytosis or 
endocytosis exogenous antigens 
get into the endosome. Later the 
endosome fuses with lysosomes to 
become endolysosomes containing proteolytic enzymes. Peptides generated 
here by proteolysis –from exogenous proteins or from engulfed or parasitic 
microbes– can form a complex with MHC II molecules.  
Similar to MHC I, MHC II molecules are synthesized in the endoplasmic 
reticulum. However here they associate with a different set of chaperone 
proteins, most importantly with the so-called invariant chain (Ii). The main 
functions of the invariant chain is to form a complex with MHC II thus prevent 
binding of endogenous peptides into the peptide binding groove of MHC II and 
transport of the complex through the Golgi-apparatus in this ‘blocked’ state. In 
the endolysosome, proteolytic enzymes degrade the invariant chain, making 
the binding site available for peptides derived from extracellular antigens. 
Usually 10-20 amino acids long peptides bind to MHC II molecules, however, 
since its binding site is ”open at both ends”, longer, overhanging peptides are 
also able to fit. After peptide-binding, the MHC II-peptide complex appears on 
the cell surface to present antigens to CD4+ helper T cells. In return, activated 
Figure 10. Peptides derived from 
extracellular pathogens are 
presented on MHC II molecules 
Following engulfment, peptides of 
the pathogen appear on the cell 
surface in association with MHCII 
molecules. The MHCII-peptide 
complex is recognized by helper T 
cells. 
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helper T cells are able to influence the immunological functions of the antigen 
presenting cells in several ways: 
 Activated effector T-helper cells facilitate the activation and 
subsequent antibody production of the antigen presenting B cells, thus 
they support the humoral immune response. 
 In case of antigen presenting macrophages the effector T-helper cells 
further activate them, increasing their efficiency in killing 
phagocytosed bacteria “settled in” in their endosomes. 
 
Features of the MHCI and MHC II molecules 
 MHC I MHC II 




source self or foreign proteins self or foreign proteins 
size 8-10 amino acids 10-20 amino acids 
origin 




Site of peptide generation cytoplasm endolysosome 
MHC transport 
remains in the ER till the 
complex formation 
Invariant chain directs it to 
specialized vesicles 
Site of peptide loading of 
MHC 
ER specialized vesicles 
MHC-peptide complexes 
on the cell surface 
reflect the intracellular 
environment 
reflect the extracellular 
environment 
 
Taken together, activated CD4+ helper T cells increase the activation and 
facilitate the function of the antigen presenting cells, while activated CD8+ 
cytotoxic T cells induce death of the antigen presenting cells. 
So far, little has been discussed about the antigen recognition of naïve T cells. 
Naïve T cells are activated in the secondary lymphoid organs. T cells that have 
not met their specific antigen can be most efficiently activated by dendritic 
cells. These professional antigen presenting cells in addition to the MHC 
molecules express those cell surface molecules, which provide effective 
stimulation for naïve T cells. 
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Activated naïve T cells proliferate and differentiate into effector T cells, which 
later will be able to carry out the above mentioned functions of cytotoxic and 
helper effector T cells.  
B- and T cell receptors 
The human population is threatened by a plethora of different microbial 
species. Moreover, even a single species can have altered variants with 
different pathogenicity. The specific recognition of this enormous variability 
requires (at least) an equal number of receptors efficiently recognizing a given 
variant of a particular microbe. The B cell receptor, its soluble form the 
antibody and the T cell receptor are glycoproteins produced in humans with a 
diversity that far exceeds that of the pathogens. One receptor is responsible for 
the recognition of a single pathogen, however the billions of receptor variations 
together are able to specifically recognize every pathogen. 
The antibody (immunoglobulin) is a symmetrical molecule that consists of 4 
polypeptide chains in humans, 2 identical shorter so-called light chains and 2 
identical longer heavy chains (Figure 11). Each chain contains constant and 
variable domains (protein subunits). The light chains consist of a variable and 
a constant domain while the heavy chains have one variable domain and –
depending on their type– 3 or 4 constant domains. The heavy and light chains 
as well as the two heavy chains are linked by covalent disulphide bonds 
(disulphide bridges between the cysteine amino acids). Additional 
intramolecular disulphide bridges stabilize the globular structure of each 
domain. As a result, a symmetrical Y-shaped structure is created, with 2 arms 
containing a light chain and the variable– and the first constant domain of a 
heavy chain. The variable domains at the end of the arms form the antigen 
binding site. The stem of the Y-shaped structure is built up from the 2 or 3 
constant domains of the 2 heavy chains. The constant domains provide stability 




Diversity is characteristic of the variable domains instead of the whole 
molecule. Variable domains are responsible for the recognition of the vast 
number of different antigens. While the number of variable domains with 
different sequences is extremely high, based on the variety of the constant 
domains the heavy chains can be divided into 5 major types (IgM, IgD, IgG, 
IgA, IgE) and the light chains into 2 types (ĸ and λ). These types are also 
known as isotypes. 
The antigen binding site of the human immunoglobulin is formed by the 
variable domains of a light- and a heavy chain together. Therefore, the heavy 
and light chains together and not alone, are able to recognize a given antigen 
with high specificity. Since the basic unit of antibody is a symmetrical 
molecule (consisting of 2 identical heavy- and 2 identical light chains), it is 
capable of creating a dual, two pronged, so-called bivalent interaction with the 
specific antigen or bridge together two specific antigens. 
Figure 11 Structure of the 
antibody 
The antibody molecule 
consists of 2 identical heavy 
chains and 2 identical light 
chains. The terminal variable 
domains are responsible for 
antigen recognition, while the 
constant domains stabilize the 
structure of the molecule and 
are responsible for the 




Figure 12. The cell surface- and soluble forms of the immunoglobulin 
The immunoglobulin molecule is expressed on the surface of B cells where it functions as their 
antigen recognition receptor. Following antigen binding it transmits activating signals into the 
cell through associated signalling molecules. The immunoglobulin is expressed in a soluble 
form as well, secreted by plasma cells which had differentiated from activated B cells. The 
roles of soluble immunoglobulins are to inactivate pathogens and to facilitate their elimination. 
The immunoglobulin molecules are produced in 2 forms during the immune 
response: 
1. It is highly expressed on the surface of B cells. In this case the heavy 
chains contain an additional transmembrane region which anchors the 
molecule to the cell membrane. The cell surface-bound 
immunoglobulin interacts with other membrane-anchored molecules 
which are responsible for signal transduction. The cell surface-bound 
immunoglobulin and the associated signaling molecules together are 
called B cell receptor (BCR) (Figure 12). 
2. The immunoglobulin/antibody can have soluble form as well. 
Antibodies are produced by plasma cells differentiated from B cells. 
Plasma cells do not express cell surface-bound immunoglobulin 
anymore, instead, they produce soluble immunoglobulins continuously 
and secrete them into the extracellular space. Structurally, the secreted 
antibody molecule is almost identical to the cell surface 
immunoglobulin. It recognizes the same antigen as the BCR, only the 
transmembrane region is absent, without which it fails to attach to the 




The BCR is responsible for both the recognition of antigens and the activation 
of antigen specific B cells. 
Soluble antibodies facilitate the recognition and contribute to the elimination 
of pathogens using other components of the immune system. (described in 
more detail at antibody effector functions) 
 
The T cell receptor (TCR) is the antigen recognition receptor of the T cells. 
Its structure is similar to the immunoglobulin. Its antigen recognition site is 
formed by 2 polypeptide chains (the α and β chain in the case of the so-called 
αβ T cells or the γ and δ chains in the case of the γδ T cells). Each chain consists 
of a constant and a variable domain. Similar to the immunoglobulin, the chains 
are linked to each other by covalent bonds and further disulphide bridges 
within each chain stabilize the globular structure. The 2 variable domains 
together are responsible for the recognition of the antigen in a form of an MHC-
peptide complex, while the constant domains stabilize the structure of the 
receptor. The chains are anchored to the cell surface by transmembrane 
domains. As part of the receptor complex non-covalently associated signaling 
molecules are present. These signaling chains are collectively called the CD3-
complex (Figure 13). 
From the point of the structure and function, there are important differences 
between the BCR and the TCR. TCR unlike BCR has only 1 antigen binding 
site and it does not exist in a soluble form, so the sole function of the TCR is 
antigen recognition followed by the activation of the T cell. 
Figure 13. The 
structure of the T cell 
receptor (TCR) 
The T cell receptor 
consists of 2 
polypeptide chains. 
The variable domains 
of the TCR recognize 
the MHC-peptide 
complexes, while the 
constant domains 
ensure the stability of 





Recognition of microbes by receptors of the immune system 












B cell B cell receptor (BCR) almost any structure 
T cell T cell receptor (TCR) MHC-peptide complex 
Various cell types of 
the immune system 
(especially the innate 
immune cells)  
Fc- and complement 
receptors  
Opsonins bound to 
antigens, foreign structures 
(antibodies, complement 
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Generation of Lymphocyte diversity  
One of the major findings of immunology was the clarification of how the 
enormous diversity of antigen receptors is produced, using the relatively low 
number of genes present in the human genome. In fact, the immune system has 
developed highly efficient molecular genetic mechanisms for the generation of 
an extremely diverse set of antigen receptors from a limited number of 
inherited genes. Without this unique mechanism, recognition of many millions 
of different antigens would not be possible. The variable domains of the BCR 
and TCR are encoded by gene segments which are often located far away from 
each other in the DNA. While conventional genes encode the constant domains 
of immunoglobulin chains (heavy- and light) and the TCR chains (α and β), 
the variable domains are encoded by gene sequences which are created by the 
joining of multiple small gene segments by a random somatic recombination 
process. The variable domains of the receptors are combined from 2 or 3 gene 
segments. These gene segments are present in many (10-100) variations in the 
DNA. During their development lymphocytes start rearranging their original 
DNA (so-called germline DNA) to create unique “novel” DNA sequences 
originally not present in the germline of the host. 
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The variable domains of the heavy chain of the BCR and the β-chain of the 
TCR are randomly assembled from three gene segments, while the light chain 
and the α-chain variable regions are assembled from 2 segments. Random 
recombination of gene segments provides the basis of the so-called 
combinatorial diversity, which allows generation of over a million different 
receptor specificities for both T- and B cells. The diversity is further increased 
by several orders of magnitude due to inaccurate joining of the gene segments 
during gene rearrangement (some nucleotides are deleted and additional 
nucleotides are randomly added at the junctions points using appropriate DNA 
modification/repair enzymes). As a result the base sequence is altered, new 
sequences appear which again, were not present in the germline sequence. The 
junctional and combinatorial diversity together are able to generate around 1014 
different B cell receptors and 1018 different T cell receptors.  
Taken together, these recombination and repair processes create a new 
randomly generated gene sequence, which encodes the variable domain of the 
antigen recognition receptor in that particular lymphocyte. Importantly, the 
constant domains are not subject to the above assembly mechanisms, therefore 
not polymorphic among individual lymphocytes of the host.  
Once the recombination process has been completed expression of the newly 
assembled gene is initiated. Only the rearranged gene sequence can be 
transcribed and translated into a protein from the mature mRNA. Following a 
productive rearrangement (that leads to the synthesis of structurally intact 
chains of the receptor), further rearrangements are blocked in that particular 
cell.  
The diversity of the antigen receptors randomly assembled by the above 
described mechanism is further increased by the fact that both the TCR and the 
BCR are formed as heterodimers randomly chosen from the pool of available 
diverse polypeptides: from the heavy and light chains in B cells and from the 
α and β (or γ and δ) chains in T cells. The binding site of the receptors is formed 
by both polypeptide chains which together determine receptor specificity.  
Clonal selection of T- and B lymphocytes and development of 
tolerance 
10 million-1 billion B and T cells are generated and mature daily in the bone 
marrow and in the thymus, replacing the dying cells in the peripheral tissues. 
Lymphocytes recognize the antigen with their cell surface-expressed B cell 
receptors or T cell receptors. The antigen recognition receptors (BCR or TCR) 
are unique with different specificity and each lymphocyte expresses only one 
type of antigen recognition receptor of the same specificity. Thus one cell is 
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specialized for the recognition of only one antigen. Overall, lymphocytes 
produced on a daily basis represent ~107 – 109 different antigen specificities. 
As a result, our lymphocytes together are able to recognize millions of different 
antigens at any time. (In contrast with this, the innate immune system uses only 
a few dozen different receptors for recognition of highly conserved pathogen-
associated structures.)  
Lymphocytes develop in the primary lymphoid organs in the absence of 
foreign antigens. As the specificity of the antigen recognition receptors is 
generated by a completely random process, in addition to pathogen-specific 
receptors, many self-reactive receptors are also produced. In the special 
environment of the primary lymphoid organs, those lymphocytes that 
recognize self-structures with high “intensity” (have high affinity receptors for 
self-proteins) die or become inactivated in the early stage of their development. 
This process, called the development of central tolerance, ensures that the 
vast majority of strongly self-reactive, potentially autoreactive lymphocytes 
are not allowed to leave the primary lymphoid organs. 
Mature lymphocytes that have completed their developmental program leave 
the primary lymphoid organs and through the blood circulation, regularly enter 
the secondary lymphoid organs in search for their specific antigen from the 
periphery. If they do not encounter their specific antigen, they continue their 
circulation in the blood and lymph to monitor the antigen repertoire of other 
secondary lymphoid organs. 
Since each lymphocyte is specialized for one particular antigen, the majority 
of them will never find their specific antigen. 
Those newly developed lymphocytes, for which specific antigen is not present 
in the body, spend only a few weeks in the circulation, then die by apoptosis, 
because in the absence of their specific antigen they are not needed. This also 




Figure 14 Clonal expansion of lymphocytes 
From the large amount of different B cells those recognizing the pathogen start to proliferate 
and form a clone (clonal proliferation/clonal expansion). Non-specific B cells re-enter the 
circulation to “find” their specific antigen in the body. Without activation signals generated by 
antigen binding B cells die by apoptosis in a few weeks. Different pathogens activate a 
different set of specific B cells. Clonal proliferation is characteristic of B- and T cells only. 
However, in the presence of pathogens, pathogen-specific lymphocytes present 
in the regional secondary lymphoid tissues become activated. Their frequency 
can range from 1:1000 to 1:100000. 
Remarkably, it is the collection of pathogen-derived antigens that “selects” the 
antigen-specific lymphocytes from the available repertoire. The recognition of 
antigen leads to the activation and proliferation of the specific lymphocyte. 
The resulting progeny cells have identical specificity providing this way the 
large number of antigen-specific cells required to control even a massive 
infection. (Figure 14).  
After elimination of the pathogen, its antigens disappear from the body, thus a 
large number of pathogen specific effector lymphocytes is not needed 
anymore. At the final stage of the immune response these unnecessary effector 
cells die by apoptosis. 
However some of the specific B and T cells differentiate into memory cells or 
long-lived effector cells, to ensure a quicker and more efficient immune 
response in case of reinfection. 
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In the case of B cells the strength/ affinity of the antigen binding usually 
improves during the clonal proliferation due to point mutations introduced into 
the coding region of the antigen recognition receptor. Cells expressing these 
slightly modified receptors must bind the antigen to survive. Lymphocyte 
clones with BCR mutations resulting in binding to the antigen with higher 
affinity will win the competition for the available antigen, thus survive and 
proliferate. As a result, at the end of this selection process B cells recognizing 
the same pathogen, with higher affinity will be produced. This process called 
“affinity maturation” requires the contribution of helper T cells. 
Functions of B cells and effector functions mediated by 
antibodies  
Antigen presentation by B cells 
Similar to dendritic cells and macrophages B cells are professional antigen 
presenting cells. The recognition of antigen by BCR induces not only 
activation, division and differentiation of the B cell, it also induces endocytosis 
of the bound antigen. The BCR-bound antigens can be efficiently internalized 
by B cells by the process of receptor-mediated endocytosis. Internalized 
antigens are processed and presented on the surface of B cells as peptide-MHC 
II complexes (as previously described in the concerning MHC II molecules). 
By this mechanism the protein antigens recognized by B cells can “be seen” 
by T cells as well. Under these circumstances, chances are good that the B cell 
and the T cell will recognize the same antigen, but not necessarily the same 
part (epitope) of the antigen. Antigen presentation by MHC II leads to the 
activation of helper T cells. The activated T cell can produce cytokines that 
facilitate activation and differentiation of B cells. During cellular contact T- 
and B cells mutually activate each other via cell surface receptors. Please note 
that in this process a positive feedback loop is created in which two 
lymphocytes (a T-and a B cell) with the same antigen specificity mutually 
support (as well as control) each other’s function (Figure 15.). 
 46 
 
Figure 15. B and T cells may respond to the same pathogen by amplifying each other’s 
response.  
 Recognition by the BCR triggers internalization of the antigen by receptor –mediated 
endocytosis. Following processing antigen-derived peptides are presented to helper T cells. 
In turn, helper T cells produce cytokines that help activation and differentiation of B cells. 
B cell effector functions: the function of antibodies 
Antibody molecules can protect against microbes or other dangerous materials 
in two ways. First, they may directly block the binding of the pathogen or toxin 
to their cell surface receptors (neutralization) and second, indirectly, by 
marking them for destruction through mechanisms to be discussed later in 
detail.  
The B cells’ characteristic molecules are the immunoglobulins. The 
immunoglobulin expressed on the cell surface (BCR) is responsible for 
recognition of the antigen, initiation of B cell activation, however the 
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immunoglobulin produced by plasma cells (antibody) mediates the humoral 
part of the B cell immune response. 
B cells usually encounter antigens in the secondary lymphoid organs, which 
provide suitable environment for B cell proliferation. The antigens to be 
recognized by B cells enter the lymphoid tissues via the blood- or lymphatic 
vessels or even bound to cell surface proteins. B cells do not require the 
antigens to be presented by MHC molecules. Antigens can be recognized by B 
cells in their original form bound to the surface of cells. 
In response to activation by their specific antigen B cells undergo clonal 
expansion. A majority of the numerous identical daughter cells of the original 
B cell will differentiate into plasma cells, specialized to produce large amounts 
of antigen-specific antibody. It should be noted that although plasma cells do 
not express the BCR, the specificity of antibodies secreted by the plasma cells 
is identical to that of the original B cell. By clonal expansion, a few activated 
B cells may generate thousands of plasma cells, each of which is capable of 
producing billions of antibody molecules. As a result the number of antibody 
molecules produced in response to an infection far exceeds the number of 
pathogens. Different B cells recognize different parts (epitopes) of the same 
antigen. In case of complex pathogens (e.g. bacteria) several B cells with 
diverse but pathogen-specific BCRs are activated. The antibodies produced by 
plasma cells can be carried by blood to all tissues and recognize pathogens far 




Figure 16. B cell differentiation into plasma cells. 
Upon meeting with antigen, the antigen specific B cells go through clonal expansion, 
differentiate into plasma cells (or into memory cells). The plasma cells due to lacking BCR 
cannot recognize antigens, however they produce large amounts of antibodies. The antibodies 
produced by plasma cells recognize the same antigen as their progenitor B cell initially 
activated by the antigen.  
Recognition of antigen, clonal expansion, differentiation and antibody 
production are time consuming, thus an efficient B cell response requires 7-14 
days to develop following the first exposure to the antigen.  
Every B cell has a unique BCR with a single specificity, thus, protection of the 
host is provided by a set of B cell clones selected from a vast repertoire of 
unique B cells by the actual pathogen.  
Neutralization 
Plasma cells in the body continuously produce surprisingly large amounts, 
approximately 1018 antibody molecules per day. Their antibody production 
increases in response to infection. Antibodies produced by plasma cells can 
exert their effect in several ways:  
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The variable domains are responsible for binding of the antigen with high 
affinity. In case of an infection pathogens become covered with specific 
antibodies, some of which physically block pathogen cell surface molecules 
required for binding to cell surface receptors of the host. Similarly, antibodies 
binding to the active parts of various animal or microbial toxins (venomous 
snakes, spiders, tetanus), inhibit their toxicity. 
This kind of steric inhibitory effect is called neutralization, and antibodies 
delivering this effect, are called neutralizing antibodies (Figure 17.). 
 
 Figure 17. Neutralization of pathogens by neutralizing antibodies 
Immunoglobulin molecules, produced by plasma cells, bound to pathogens or different toxins 
may inhibit their effects. They can block binding of pathogens (e.g. viruses) to the cell surface, 
thus preventing infection of the cell. 
Antibodies produced by the mother’s immune system can be transported 
through the placenta or into the breast milk. These antibodies protect the new 
born from infections for several months after birth, until the child’s own B cell 
repertoire is fully developed. This maternal protection mechanism is also based 
mainly on neutralizing antibodies. Large amounts of neutralizing antibodies 
are produced on a daily basis by the immune system of the intestines, these 
antibodies are transported into the lumen, where they neutralize the dangerous 
materials taken up together with food. Some life-saving medical treatments 
utilize the direct neutralizing effects of antibodies. For example: upon a snake 
bite, antibodies neutralizing different toxins of the snake venom are given to 
the patient. (See the part about passive immunization!) 
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While neutralization is based primarily on the variable region of the antibody, 
other effector functions are dependent on the constant regions of the antibody 
molecule, more precisely on the Fc region.  
The Fc region of the antibody (the “stem” of the Y- or fork-shaped antibody 
formed by the constant domains of the heavy chains) is recognized by various 
cell surface receptors, called Fc-receptors, expressed on several types of 
immunocytes. With these receptors, immune cells can recognize antibody 
molecules. Antibodies form a bridge between the opsonized pathogen and the 
immunocyte. The variable domain of the antibody binds to the pathogen, while 
the Fc region binds to the Fc receptor expressed on the immunocyte.  
Unlike the variable domains of the antibodies the constant domains are more 
or less identical. (The different isotypes are recognized by distinct Fc 
receptors). Thus phagocytes and NK cells don’t need to produce a diverse set 
of unique receptors for the recognition of millions of pathogens, they “smartly” 
recognize the Fc region of opsonizing antibodies attached to any pathogen. 
Importantly, most Fc-receptors are not activated by free antibodies. Efficient 
activation of phagocytes or NK cells via their Fc-receptors requires immune 
complexes. Thus we can say that these receptors are responsible for the 
recognition of opsonized antigens. 
Effector mechanisms mediated by the Fc part of the antibodies 
 Opsonization by immunoglobulins enhances receptor mediated 
phagocytosis of pathogens via cell surface expressed Fc-receptors. 
(Figure 18.)  
 NK cells also express Fc receptors. With these receptors, they are able 
to bind cells opsonized by immunoglobulins. This interaction may 
trigger their cytotoxic function. This process is called antibody 
dependent cellular cytotoxicity (ADCC). (Figure 18.)  
 The Fc region of many immunoglobulin isotypes contains complement 
binding sites. Such antibodies bound to the pathogen can activate the 
complement system. (Figure 18.). 
 Fc-receptors recognizing the heavy chains of IgE, play a key role in the 
induction of allergic reactions, by activating mast cells and basophil 
granulocytes. (As described later!) 
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Figure 18. Antibody mediated effector functions 
In addition to neutralization, binding of antibodies to pathogens (opsonization) may facilitate 
phagocytosis of the pathogen, may activate the complement system and the NK cells as well.  
Immunoglobulins – based on the structure of their heavy chain – are classified 
into five major classes, called isotypes: IgM, IgD, IgG, IgE and IgA. However, 
in response to adequate stimuli (with the contribution of helper T cells) the B 
cell can change the isotype of the produced antibody by a process called 
isotype switching or class switching. The cells of the immune system have 
different Fc-receptors on their surface that recognize and bind specific 
antibody isotypes. Importantly, different types of Fc receptors deliver distinct 
effector functions. As a result, by changing the isotype (but not the specificity) 
of the produced antibodies, the formed immune complexes or the opsonized 
pathogens will bind to a different set of Fc-receptors, thus the effector 
functions induced by them usually change.  
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There are some special Fc receptors in the body, which are responsible for the 
transport of antibody molecules. Such Fc-receptors transport IgG from the 
mother to the fetus, or IgA across epithelial cells or into the breast milk.  
It’s important to emphasize that during isotype switching, not the specificity, 
but the effector functions of the antibody are altered. As binding specificity 
remains the same, neutralizing function of an antibody is not influenced by 
isotype switching. 
Effector functions of the main antibody isotypes: 
 Immunoglobulin G, or IgG is the „swiss army knife” of antibodies. 
This isotype can efficiently opsonize pathogens and facilitate the 
process of phagocytosis. Some subtypes effectively activate the 
complement system as well as the killing function/capacity of NK cells. 
This isotype is present at the highest concentration in plasma, and has 
the longest half-life. Special Fc receptors transport IgG, from the 
mother’s circulation into the fetus across the placenta. 
 IgM Many species of bacteria opsonized by IgM can be destroyed 
efficiently by the complement system. This type of immunoglobulin 
can be found on the surface of naïve B cells where they function as 
antigen binding receptors. Unlike IgG, this immunoglobulin is not able 
to facilitate the phagocytosis of bacteria directly (only by activating the 
complement system). IgM can be transported by Fc receptors, but not 
from the mother to the fetus.  
 IgA It appears in body fluids including tear, saliva, intestinal fluids, 
mainly to protect cells of the mucosal epithelium. Transport of IgA 
mediated by specific Fc receptors is considered the most efficient 
among antibodies. 
 IgE its natural function is protection against parasites, however this 
immunoglobulin isotype is responsible for the symptoms of allergic 
reactions. 
 IgD This isotype is present primarily as an antigen-specific receptor on 
the surface of newly formed B cells. Similar to IgM, IgD plays a role 
in B cell activation.  
T cells 
T-lymphocytes express a cell surface antigen receptor called T Cell Receptor 
(TCR) which resembles an antigen-binding arm of an antibody. 
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The antigen-specific activation of T cells requires direct contact between the T 
cell and an antigen presenting cell as it requires the interaction of the TCR and 
MHC molecules. In contrast to B cells, the majority of T cells exclusively 
recognize protein-derived peptide epitopes in complex with the 
histocompatibility complex (MHC) proteins. 
 
Differences in antigen recognition by B and T cells. 
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The two main populations of T cells contribute to the immune response 
differently. Helper T-lymphocytes have more of a regulatory role in the 
immune response while cytotoxic T-lymphocytes are professional killer cells 
designed for killing of infected- or tumour-cells directly. 
Completing their development in the thymus both naïve CD4+ (“helper”) and 
naïve CD8+ T (“cytotoxic”) cells enter the circulation. Leaving the blood, they 
migrate into secondary lymphoid organs and screen the local antigen-repertoire 
on the surface of dendritic cells available at the time of their surveillance. A 
continuous recirculation of T cells between various secondary lymphoid 
organs is maintained until circulating T cells meet their specific antigen that 
induces their activation, followed by clonal expansion and differentiation into 
effector T cells. Clonal proliferation of T cells, like that of B cells rapidly 
generates a large population of cells (a T cell clone) with antigen specificity 
identical to that of their progenitor cell. Those T cells that fail to find their 
specific antigen are destined to die by apoptosis within a few weeks.  
In most cases antigens for naïve T cells are transported into the lymph node by 
dendritic cells. Dendritic cells dispersed in tissues sense pathogens using their 
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pattern recognition receptors. Upon recognition they engulf microbes and 
migrate into the regional lymph node. Meanwhile, processing of the pathogen-
derived antigen is completed and peptide fragments are presented on MHC. 
Thus, initial activation of T cells occurs in a special environment, the lymph 
node, where clonal expansion of antigen-specific T cells occurs. Those T cells 
that have gone through clonal expansion and differentiation exit the lymph 
nodes. Once in the periphery, they are able to deliver a proper response upon 
the second activation by the same antigen present at the site of infection. 
In the periphery, cytotoxic T cells (Tc) recognize their specific peptide 
fragment (antigen) presented by any nucleated cell expressing MHC I 
molecules. Notably, these antigen presenting cells recognized by Tc are 
usually infected or tumour cells. 
Helper T-lymphocytes (Th cells) can only be activated by professional antigen 
presenting cells expressing cell surface MHC II molecules in peripheral tissues 
and also in peripheral lymphoid tissues.  
 
Figure 19. The main populations of T cells: helper and cytotoxic T-lymphocytes 
T cell subsets and their functions 
Helper T cells or Th cells are not directly involved killing of pathogens, they 
rather coordinate the immune response by communicating with other 
immunocytes. Exogenous proteins processed to peptides by professional APCs 
and presented to CD4 co-receptor expressing Th cells via cell surface MHC II 
molecules. Antigen-specific activation of Th-cells via the TCR induces 
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cytokine production and expression of novel cell surface molecules on the T-
lymphocyte by which they coordinate the immune response. (Figure 19.) 
We can distinguish some major helper T cell types, type 1 (Th1), type 2 (Th2) 
type 17 (Th17) and follicular helper T cells. Th1 cells are essential 
components of the immune response against intracellular pathogens. 
Cytokines secreted by Th1 cells are involved in the recruitment if phagocytes 
to the site of infection and enhance the antimicrobial (killing) activity of 
macrophages, the killing functions of NK- and cytotoxic T cells.  
Th2 cells on the other hand help the immune response essential for the 
elimination of parasites and helmiths. By their cytokine secretion they facilitate 
the control of parasites by mast cells, basophil- and eosinophil granulocytes. 
In addition, macrophages activated by the same cytokines play an essential role 
in tissue re-building (repairing tissue damage) once the pathogens had been 
cleared.  
Another, important subpopulation of Th cells is the Th17 subset, partaking in 
immune responses against extracellular pathogens, bacteria or fungi in 
particular. They potentiate inflammatory responses by recruiting neutrophils 
and monocytes to the site of infection. Th17-cells can be found in large 
numbers near the epithelial barriers. 
While Th1, Th2 and Th17 cells migrate and function to the peripheral tissues, 
follicular helper T cells facilitate the activation and differentiation of B cells 
in the secondary lymphatic organs. Their function is essential for the process 
of isotype switching of antibody molecules. This cell type was identified 
recently, before that, their function was assigned to classical Th1 or Th2 cells.  
T-helper subsets can develop from the common naïve Th precursor (a Th0 cell) 
in secondary lymphoid organs. Their differentiation is predominantly 
regulated by the APC of the local secondary lymphoid tissues, however, 
cytokines in their environment have also profound regulatory functions. For 
example, secreted cytokines by the Th1 and Th2 subsets mutually inhibit each 




Figure 20. Differentiation of naïve helper T cells 
Interaction with the APC, together with their cytokine secretion will determine the “fate” of 
the differentiating naïve T-helper cell. Various T cell subsets differentiating from the activated 
Th0 cells coordinate distinct immune cell functions. Th1 cells secrete cytokines mainly to 
enhance the immune response against intracellular pathogens, while Th2 support anti-parasite 
immunity. Cytokines produced by different T-helper subpopulations inhibit each other’s 
function. 
Cytotoxic T cells (killer cells, CTL, CD8+ T cell) recognize and kill 
“estranged”, virus-infected or tumour cells present in our body. Under 
physiological conditions our cells continuously synthesize and degrade cellular 
proteins. Peptides derived from these degraded proteins are transported to the 
cell surface and displayed in complex with MHC I molecules. The same 
mechanism operates for the presentation of viral- and tumour-associated 
proteins. 
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Unlike Th cells, CTLs recognize antigen fragments in complex with MHC I 
molecules expressed by all nucleated cells, thus synthesis of foreign or mutant-
self proteins in any cells can be readily detected and eliminated by CTLs. 
(Figure 19.) 
Although the mechanism of recognition and activation of NK cells and CTLs 
are different, the mechanisms of killing the target cells are similar. Both cell 
types make contact with the infected- or tumour-cell directly and releases the 
content of their intracellular granules containing cytotoxic substances to the 
site of cell-cell contact. Some of these cytotoxic substances like perforin 
molecules will form pores within the target cell membrane leading to 
disruption of the transmembrane ion balance which alone may be sufficient to 
cause the death of the target cell. 
Granzymes also released by these granules enter the target cell via perforin-
induced pores and trigger apoptosis. Additionally, effector CTL expresses 
molecules on the surface which induce apoptosis in the target cell. 
Various subsets of regulatory T cells produce inhibitory cytokines that 
suppress immune responses against self-antigens. 
The immunological memory, passive and active 
immunization 
The appearance of the adaptive immune system during evolution allowed the 
specific recognition of unique antigens which is essential for the development 
of the immunological memory. In case of repeated exposure to the same 
pathogen the organism responds faster and more effectively compared to the 
first exposure. Memory response is characteristic only of B and T cells. The 
mechanism of pathogen recognition by innate cells does not allow the 
development of an effective, highly-specific memory response.  
During clonal proliferation and differentiation, some antigen-specific B and T 
lymphocytes in the secondary lymphoid tissues differentiate into memory 
cells. The memory cells and their precursors have the same antigen receptor 
specificity therefore they recognize the same antigen. Following elimination 
of the pathogen, the majority of antigen specific B and T cells becomes 
unnecessary and die by apoptosis. However, a relatively large number of 
lymphocytes survive and become memory cells. After elimination of the 
pathogen, memory cells may survive and preserve their antigen specificity for 
decades, even in the absence of their specific antigen. B cells can differentiate 
into long-lived plasma cells and may produce antibodies throughout the entire 
lifetime of an individual.  
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Characteristics of the memory response 
 Upon second exposure (with the same pathogen), antibodies produced 
by long-lived plasma cells act immediately to neutralize and opsonize 
the pathogen  
 The frequency of specific lymphocytes upon antigen re-exposure 
within the long-lived memory T or B cell repertoire is much higher than 
in the repertoire of naïve lymphocytes. 
 Activation of B as well as T memory cells is simpler, thus faster than 
that of naïve cells. 
 
Figure 21. The response of memory B cells. 
After the specific recognition of the pathogen B cells go through clonal expansion and 
differentiate to plasma cells or memory B cells. Following successful eradication of a pathogen 
the majority of the plasma cells die, however, some of the antigen specific long-lived plasma 
cells and memory B cells survive. Re-infection with the same pathogen induces the activation 
of already existing memory cells. In this population, frequency of antigen-specific B cells is 
higher than in naïve B cell populations. In addition, they are already differentiated B cells that 
have gone through a germinal center reaction, which warrants a faster, more robust and more 
effective B cell response. The amount, the specificity and the affinity of the secreted antibodies 
are also higher.  
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Antigen-specific effector cells, which develop from memory cells in peripheral 
tissues or in secondary lymphoid organs complete their proliferation and 
differentiation more rapidly. 
Compared to the first encounter (primary immune response), the memory 
response reaches its peak three-times faster (within 3-5 days). 
 During a memory response not only the number of responding B cells 
but the amount of antibodies produced is higher compared to the 
primary immune response (Figure 21.) 
 Both the affinity and the specificity of antibodies produced during the 
memory response are enhanced (affinity maturation) and often their 
isotype is switched. In a primary response IgM-type antibodies are 
dominant, while repeated infections with the same pathogen increases 
the amount of other isotypes (IgG, IgA, IgE) 
The differentiation of long-lived plasma cells, affinity maturation as well as 
isotype switching of B cells requires the contribution of Th cells.  
With ageing the production of naïve lymphocytes decreases. Thus, in elderly 
people the immune response is based on memory lymphocytes. Senior people 
may be sensitive to infections with pathogens yet unknown to them, however 
they can readily maintain protection against microbes they have encountered 
long time ago. 
 
The B cell mediated primary and secondary immune response 
 primary response memory response 
Intensity lower high 
Antibody isotype mainly IgM (IgM) IgG, IgA, IgE 
Antibody affinity low affinity high affinity 
Time interval of a 
max. response 
7-14 days 3-5 days 
Immunization 
The beneficial features of the memory immune response are utilized when 
artificial immunization is used to develop protection against pathogens. Using 
passive immunization, antigen-specific antibodies are injected or transfused 
into to body. By active immunization both cellular and humoral antigen-
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specific memory response are induced artificially that usually prevent the 
appearance of the disease following exposure to pathogen.  
Passive immunization 
Immunity can be transferred from one person to another. Antigen specific 
antibodies or antibody-enriched serum (antiserum) can be transfused to a 
person we aim to protect. These antibodies act immediately, neutralize and 
opsonize the antigen.  
The application of antiserum or purified antibody is warranted in all cases 
when fast and efficient protection is needed immediately (when the antigen has 
entered the body). For example, serum containing neutralizing antibodies are 
used in cases when venom of poisonous snakes or a toxin of arthropods enter 
the victim’s body.  
The protection time of passive immunization is limited by the half-life of the 
antibody (usually some days to some weeks depending on the subtype). 
Newborns are protected from many pathogens by antibodies produced by their 
mother. Until birth, IgG antibodies are transcytozed from the maternal to the 
fetal blood via the placenta by special Fc receptors. After birth these antibodies 
provide temporary protection distributed in the body of the newborn. The 
baby’s digestive and respiratory tract are protected by the maternal IgA 
supplied by breast feeding. 
Active immunization and vaccines 
An immune response can be induced by either infection or active 
immunization. Vaccines may contain live attenuated or inactivated 
pathogenic microbes, purified or artificially synthetized immunogenic 
components/subunits of microbes. Attenuated pathogens lose some of their 
virulence factors essential for fast proliferation and dissemination. This blocks 
their ability to induce serious disease, but allows the development of protective 
immunity by the host. Vaccines containing small parts or purified recombinant 
proteins of microbes called subunit vaccines are usually less efficient and 
require the use of adjuvants. The pathogen-derived antigens are recognized by 
the adaptive immune system and a memory response is generated, but most 
vaccines will induce transient, mild symptoms only, if any. 
Vaccines prepare the immune system for a future infection. During vaccination 
the immune system completes all the steps of the relatively slow primary 
response, therefore a future response to an infection with the pathogenic 
microbe will show the characteristic of a rapid and robust secondary (memory) 
response that clears the infection quickly. Vaccination may completely block 
or dampen the symptoms of infections. Taken together, vaccination against a 
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microbe mimics the infection with the pathogen, induces a memory response 
which enables the host to eliminate the same pathogen and prevent a 
potentially fatal disease.  
Active immunization with most vaccines is a slow process. It takes weeks or 
sometimes months to develop effective protection and sometimes repeated 
vaccination is required. Thus, an immediate response is not provided, but 
depending on the type of the vaccine it may protect the body against the 
targeted microbe for decades or even for life. Good examples of this are 
vaccines given to children at an early age. 
The efficacy of a vaccine, just like the imunogenicity of antigens in general, 
may differ significantly from one person to another. Immunodeficient 
individuals may remain unprotected to some or to all pathogens despite the 
most sophisticated vaccination schemes. However, when the majority of 
individuals within a large human population are vaccinated, these unprotected 
individuals of the group are also protected. This phenomenon is called the 
“herd immunity”, a kind of “social immunity”. 
 
Active and passive immunization. 
 Active Passive 
Type of substance 
inactivated/attenuated 
pathogen, or pathogen 
subunit 
immune serum or 
purified antibody  
Mechanism 
the host develops an 
immune response 
memory cells produced 
exogenous, neutralizing 






long: years or lifetime  some weeks or months 
Immunological tolerance 
B and T cells of a healthy individual will fail to launch a destructive immune 
response to antigens present in self-tissues. This is a result of an active, antigen 
specific unresponsiveness as a result of two main mechanisms called central- 
and peripheral tolerance.  
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Central tolerance is established during lymphocyte development in the 
primary lymphoid organs, for B cells in the bonne marrow and in the thymus 
for T cells. Antigen receptors of lymphocyte progenitors are exposed to self-
antigens during their development. Those cells carrying receptors that bind to 
self-antigens with high affinity are considered potentially autoreactive and die 
by apoptosis. Thus, most self-reactive, potentially dangerous autoimmune cells 
prone to cause tissue damage in various organs are eliminated at an early stage 
of lymphocyte development. This process generating central tolerance is 
referred to as negative selection or clonal deletion of autoimmune 
lymphocytes. Even though there are mechanisms inducing the ectopic 
expression of self-antigens in the primary lymphoid organs, some developing 
lymphocytes fail “to get acquainted” with all self-antigens. Thus central 
tolerance is considered an efficient but “leaky” mechanism.  
Autoimmunity caused by the relatively few self–reactive cells can be 
controlled by various peripheral tolerance mechanisms. 
1. As described above, naïve T-lymphocytes acquire activation signals 
exclusively from activated, mature dendritic cells (DCs) immigrating 
from the site of infection to the lymph node. DCs exposed to danger 
signals or pathogen associated molecular patterns elevate the cell 
surface expression of co-stimulatory molecules which are required for 
the proper activation of naïve T cells. The “maverick” autoreactive T-
lymphocytes escaping clonal deletion in the primary lymphoid organs, 
will first encounter their specific self-antigen presented by non-
professional APC, or non-activated APC in the absence of co-
stimulation. In the absence of co-stimulation these T-lymphocytes 
enter into a state functional unresponsiveness called anergy. 
2. Peripheral tolerance of B cells is maintained mainly by the absence of 
autoreactive T cells. B-lymphocytes recognizing and presenting self-
antigens fail to find helper T-lymphocytes which are specific for the 
same autoantigen. In the absence of T cell mediated costimulatory 
signals activation of autoreactive B cells is inhibited.  
3. Peripheral tolerance is maintained in part by the aforementioned 
regulator T-lymphocytes (Treg) which keep autoreactive lymphocytes 
supressed.  
Communication between the innate and adaptive 
immune system 
While in invertebrate species only the elements of the innate immune system 
are present, the innate and adaptive immune systems not only co-exist in 
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humans, rather, they co-operate in total harmony. The innate immune system, 
especially macrophages and dendritic cells are essential for initiation of the 
adaptive immune response. T cells are unable to function without these antigen 
presenting cells. With few exceptions B cells also require the signals coming 
from innate immune cells and / or T helper cells. 
The cells of the innate immune system do not simply trigger the activation of 
T cells. Through their secreted cytokines, costimulatory and adhesion 
molecules, they orchestrate the adaptive response. Although activation of the 
adaptive immune system comes much later, it is able to augment significantly 
the function of innate immune cells. 
Cytokines produced by T cells help the activation of macrophages, elimination 
of the ingested microbes, maturation of dendritic cells, antigen presentation 
and the cytotoxicity of NK cells. Lymphocyte-derived cytokines contribute to 
regulation of the action, the maturation and the localization of innate cells. At 
the same time cytokines also play a key role in limiting the innate immune 
response.  
We have already discussed the effect of antibodies produced by B cells. The 
antibody molecules opsonize pathogens, facilitate their recognition and 
phagocytosis. Opsonization by antibodies also increases the activity of the 
complement system and enhances NK cell-mediated killing. Similarly, 
antibodies regulate the function of mast cells and granulocytes.  
Both the innate and the adaptive immune system have self-control 
mechanisms. Cytokines and chemokines produced by macrophages have 
autocrine effects regulating macrophage functions. These cytokines are the 
main positive and negative regulators of neutrophils in the inflammatory 
process, and also of the functional activity of NK cells. Furthermore, they can 
increase the production and facilitate the exit of complement proteins from the 
blood vessels.  
In the case of the adaptive immune system only those B cells can get help from 
Th cells which can present appropriate antigen to them. In optimal situation 
the B cell and the interacting Th cell recognize the same antigen. In this case, 
cytokines produced by the T cells contribute to the activation, affinity 
maturation of B cells as well as to generation of memory cells. Antigen 
presentation by B cells may facilitate the survival of effector / memory T cells. 
The process of immune response 
Pathogens may cause mild diseases, like rhinitis induced by rhinoviruses or 
debilitating, even fatal diseases, for example the HIV or HBV virus. Our 
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immune system consists of multiple, co-operating systems which defend the 
body against thousands of pathogens present in our environment. The skin or 
the mucosal epithelium lining the airways and gut are the first defense line 
against invading pathogens, forming a physical and chemical barrier against 
infection. The dry and hard outer layer of the skin is a formidable barrier when 
unbroken. Infections occur only when a pathogen crosses these barriers, as in 
the case of an injury (e.g. wounds by cuts and burns). Although the 
gastrointestinal and respiratory tracts are exposed to a plethora of pathogens 
they are protected effectively by multiple mechanisms. Pathogens colonizing 
mucosal surfaces enhance secretion of a viscous fluid called mucus. Foreign 
agents irritate the respiratory tract triggering cough and sneezing, which 
effectively remove these irritants. The acidic environment of the stomach 
destroys many pathogens ingested with meals. 
The gastrointestinal, respiratory and urogenital tracts are covered by mucosal 
epithelium which consists of epithelial cells held together by tight junctions. 
These epithelial cells are covered with mucus, containing various oligo- and 
polysaccharides. Mucus has a number of protective functions, for example it 
may prevent microorganisms from adhering to the epithelium. 
Epithelial cells can transport certain antibody isotypes (especially IgA) across 
the epithelial cell to the surface of mucosal epithelium using active transport 
mechanisms. Therefore, microbes are exposed to antibodies as soon as they 
enter our respiratory or digestive system. IgA-mediated protection against 
microbes is based primarily on its neutralizing effect.  
Invading pathogens are encountered by various immune cells ready for 
combat. Macrophages, dendritic cells, effector T cells and B cell are all present 
in the subcutaneous or intraepithelial tissues. The invading pathogens are 
recognized first by the cells of the innate immune system (eg. macrophages 
and dendritic cells), expressing pattern recognition receptors. They 
immediately trigger the well-known reactions of the innate immune system 
(elimination of pathogens, release of cytokines, recruitment of other 
immunocytes) leading to induction of inflammation in the infected tissue.  
The increased production and flow of lymph will carry some of the pathogens 
into the regional (draining) lymph nodes. Activated dendritic cells also reach 
the lymph nodes through the lymph, where they present processed 
phagocytosed antigens to the T lymphocytes. Thus B and T lymphocytes, 
which recognize the pathogen specific antigens, get activated, proliferate and 
differentiate into effector or memory cells.  
Depending on the amount and the growth rate of the invading pathogen we can 
distinguish between three potential courses of the immune response.  
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Small amounts of pathogens are immediately recognized at the site of infection 
and are eliminated by macrophages found almost everywhere in our body.  
If this mechanism is insufficient for clearing the pathogen more participants of 
the innate immune system will be recruited to help macrophages. 
If the pathogen survives for an extended period, the adaptive immune system 
will also be activated, which finally eliminates the pathogens either by its own 
mechanisms, or more often by enhancing the innate response.  
If the organism has met the pathogen in the course of an earlier infection, the 
effector mechanisms of adaptive immune response can provide immediate 
protection. Pathogen-specific antibodies produced by the long-lived plasma 
cells neutralize the pathogens and the effector T cells eliminate the infected 
cells in a few days, or produce cytokines to enhance the efficiency of the other 
participants of immune system. In parallel, memory cells in the lymph nodes 
get activated and begin to proliferate rapidly. 
Bacteria, viruses and parasites 
 Hundreds or thousands of viruses, bacteria, fungi, unicellular or multicellular 
eukaryotic parasites are able to infect humans. Pathogens use diverse strategies 
for infection and to escape immune surveillance. Accordingly, the immune 
system uses different strategies to override these mechanisms.  
 
 
The main strategies of immune system for elimination/neutralization of 








 production of soluble 
toxic agents 
 complement system 




 destroying infected cells 
(NK cells) 
 intracellular killing and 
degradation 
 release of type I 
interferons, intracellular 
antiviral mechanisms 
 destroying infected 
cells (cytotoxic T 
cells) 
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Most pathogenic bacteria and fungi entering the body live in the interstitial 
space between cells. These pathogens are called extracellular pathogens. 
These are the main targets of antibodies and complement proteins released 
from the blood plasma during inflammation. Pathogens opsonized by 
antibodies are efficiently recognized by phagocytes, mainly by macrophages 
and neutrophil granulocytes, and by the complement system. The complement 
system can itself lyse some microbes. As a result, via complement receptors 
and Fc-receptors phagocytes are induced to ingest and kill opsonized 
pathogens.  
Dendritic cells activated by microbes induce high-level expression of 
costimulatory receptors and migrate along lymphatic vessels to draining lymph 
nodes where they present the pathogen-derived peptides to naïve T 
lymphocytes. Pathogens phagocytosed by macrophages are usually killed in 
the phagolysosomes. A fraction of microbial peptides not degraded in the 
phagolysosomes can be presented on MHC II to the helper T cells. In turn, 
effector T-helper cells activated by macrophages using cell-cell contact and 
secretion of cytokines (e.g. IFN-γ) will help macrophages to kill the ingested 
pathogens or at least prevent their spread (Figure 22). 
 
 
Figure 22 Elimination of extracellular pathogens 
Phagocytes (Mf) recognize pathogens via PRR or pathogens opsonized with antibodies and/or 
complement via Fc- and/or complement-receptors. Pathogens bound by these receptors get 
ingested and killed in the phagolysosomes by multiple mechanisms (right). Antibodies 
produced by plasma cells may neutralize the pathogen and/or activate antibody-mediated 
effector functions (middle). (Complement components may directly eliminate pathogens.) 
Type 2 cytokine-producing T helper cells augment immune response against extracellular 
pathogens primarily (left). 
 
 67 
Viruses and some bacteria are able to invade cells and generate intracellular 
infection, therefore their elimination requires an entirely different recognition 
and elimination process.  
The epitopes of intracellular proteins synthetized in infected cells are presented 
at the cell surface through MHC class I molecules. These infected cells are 
recognized and eliminated by another group of effector T cells, the cytotoxic 
T cells. If intracellular pathogens downregulate expression of MHC class I 
molecules, infected cells are recognized and eliminated by NK cells, since the 
lack of MHC class I mediated inhibitory signals greatly enhance cytotoxic 
activity of NK cells. 
Thus, effector functions against intracellular pathogens are not directed to the 
pathogen, they are rather focused on destruction of the infected host cells 
(Figure 23).  
The same effector mechanisms are also characteristic of anti- tumour 




Figure 23 Elimination of intracellular pathogens 
Virus-infected cells are recognized via intracellular pattern recognition receptors followed by 
production of type I interferons. Concomitantly, MHC class I molecules present antigens of 
intracellular pathogens on the cell surface and activate cytotoxic T lymphocytes, which kill the 
infected cells (bottom left). In the absence of cell surface MHC I (indicating an aberrant 
cellular function) cells become targets for NK cells, which again leads to the elimination of 
the cell (right). 
Interferons play a key role in anti-viral immunity. IFN-γ is produced mainly 
by T helper cells and cytotoxic cells (NK, Tc), and besides their direct antiviral 
effect their main function is to promote macrophage functions. In the presence 
of IFN-γ macrophages kill engulfed microorganisms more efficiently. In 
addition, IFN-γ enhances the expression of MHC class I and II molecules on 
the surface of professional antigen presenting cells.  
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IFN-α, IFN-β can be produced by almost any cell type following viral 
infection. Interferons often have autocrine effects on the cells producing them, 
or paracrine effects on neighbouring cells. They interfere with viral replication 
by various mechanisms eg. through inhibition of protein synthesis, or increased 
expression of MHC class I molecules.  
Antibodies may also partake in the defense against viruses. The neutralizing 
effect of antibodies prevents viral adhesion to host cells and thereby interferes 
with infection. 
Viral proteins may also be integrated in the cell membrane of infected cells. 
Antibodies recognizing these antigens will bind to them, thus marking the cell 
for antibody-dependent cellular cytotoxicity (ADCC). NK cells can kill 
infected cells also by ADCC via activation by their Fc receptors.  
Some small, unicellular eukaryotic parasite, which exist intracellularly in 
some part of their life cycle, such as Plasmodium species, can induce similar 
cytotoxic T cell responses. Their extracellular form can be recognized by 
antibodies  
Elimination of large multicellular extracellular parasites (e.g. flat- and 
roundworms) often requires much broader spectrum of immune response 
delivered by specialized cells. Mast cells, basophil and eosinophil granulocytes 
are involved in inflammation triggered by parasites. These cells release special 
toxic agents and degrading enzymes from their vacuoles to destroy the 
parasites at the area of infection. In addition to toxic agents many pro-
inflammatory cytokines are also secreted. Some of these increase peristaltic 
activity in case of intestinal infection or trigger coughing, sneezing and induce 
mucus production in case of a respiratory infection to help removing the 
parasites from the body. The parasite-specific IgE antibodies bound to high 
affinity Fc receptors of mast cells and basophil granulocytes play important 
roles in the activation of these cells and thereby in the immune response against 
parasites. 
Disorders of immune system 
“Too much” as well as “too little” reactivity of the immune system may cause 
diseases. The former may lead to the development of the so-called 
hypersensitivity reactions while the latter one is called immunodeficiency.  
Hyper-reactivity can develop against self-antigens causing autoimmune 
diseases. Hypersensitivity reactions specific to either foreign or self-antigens 
may cause significant tissue damage to the host.  
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Allergic diseases 
In some people immune response is triggered by innocuous (harmless) agents 
(allergens), such as plant pollen, certain food products (eg. peanut proteins), 
animal hair (animal-derived proteins) or house dust (which contains the 
excrement components of dust mite). These processes are connected with 
abnormal production of allergen-specific IgE antibodies by plasma cells.  
The characteristic symptoms of the disease are itching, sneezing, rashes, or in 
more serious cases, anaphylactic shock.  
This process is triggered by stable, compact, often enzymatically active 
antigens. Such antigens are able to cross the epithelium of the respiratory 
system or the gastrointestinal tract. T cells contribute to the development of the 
disease by promoting the development of antigen-specific, IgE producing B 
cells. Antigen-specific IgE antibodies gaining access to all peripheral tissues 
bind to the high affinity Fcε receptors (IgE-specific, Fc-epsilon receptors) on 
mast cells. From that point, the body is „sensitized” to the antigen. These 
sensitized mast cells survive for years.  
At the second exposure the allergen will activate many Fcε-receptors via 
crosslinking the antigen-specific IgE bound to them. Consequently, mast cells 
become activated and release their stored bioactive agents (histamine, 
serotonin, various enzymes) which rapidly induce the typical symptoms of 
allergy (immediate reaction). This rapid, usually immediate reaction to the 
antigen (allergen) is called Type I hypersensitivity reaction (Figure 24). 
Later, in the second phase of the reaction, (also called the late response) mast 
cells and basophil granulocytes produce additional inflammatory mediators 
(late lipid mediators and cytokines).  
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Figure 24 Mechanism of allergic response 
Expression of high affinity Fcε receptors on mast cells is antigen independent. After 
appearance of an allergen specific IgE-type antibodies are produced by plasma cells which 
bind to these Fcε receptors whit high affinity. Crosslinking of Fcε receptor-linked antibodies 
by the allergen induces activation of the mast cell: the release of granular content and cytokine 
production.  
The main role of the mast cells, basophil granulocytes and molecules (IgE) are 
well known in immune response against parasites. Thus most of the symptoms 
of allergic reactions results from effector mechanisms designed to kill or expel 
parasites.  
Autoimmune diseases 
Sometimes regulatory mechanisms maintaining self-tolerance fail, resulting in 
increased production of self-reactive antibodies and lymphocytes. As a result, 
healthy cells and tissues become targets of the effector mechanisms of immune 
response.  
Antibodies can be produced against various cell surface receptors this way. 
Some of these auto-antibodies may interfere with the normal function of the 
receptor by inhibiting the binding of its natural ligand (blocking or antagonistic 
antibodies). This is the case in myasthenia gravis, an auto-immune disease, in 
which antibodies specific to acetylcholine receptors at the postsynaptic neuro-
muscular junctions inhibit the excitatory effects of the neurotransmitter 
acetylcholine causing muscle weakness. Other auto-antibodies can have 
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stimulating effects on receptors (agonistic antibodies). In Graves’ disease (also 
known as Basedow-syndrome) auto-antibodies continuously stimulate the 
thyroid-stimulating hormone (TSH) receptor, resulting in hyperthyroidism. In 
other cases, binding of the auto-antibody to the target cell does not change 
cellular functions, but triggers antibody-dependent effector functions 
described earlier. In penicillin-sensitive persons antibodies recognize 
penicillin covalently coupled to cell surface proteins of red blood cells. Similar 
to any other antigens or pathogens, red blood cells opsonized by penicillin-
specific antibodies become targets of phagocytes and the complement system. 
Those reactions when antibodies bind to common or modified cell surface 
antigens and trigger effector functions causing damage to self-tissues are called 
Type II hypersensitivity reactions.  
T cells may also cause hypersensitivity or autoimmune disease by a mechanism 
called Type IV hypersensitivity. In patients with Type I diabetes mellitus 
cytotoxic T lymphocytes kill the insulin producing beta cells of the pancreas. 
In gluten-sensitive individuals the modified gliadin peptide derived from the 
wheat protein gluten is presented via MHC class II molecules to T cells leading 
to their activation that triggers the production of pro-inflammatory cytokines 
and thereby inflammation. 
Some people are sensitive to chemicals produced by plants (e.g. poison ivy), 
others to nickel-containing jewellery. When these materials come into contact 
with skin they modify skin proteins. The modified protein presenting cells 
become targets of Tc- or Th cells that induce inflammation (contact 
dermatitis). These processes –with the antigen presentation– require 48-72 
hours to develop, consequently, this type of reaction is often called delayed-
type hypersensitivity. 
Immune complex diseases 
Immune complexes are antigens opsonized with antibodies (Figure 25). 
Antibodies may form large, cross-linked complexes with antigens, which 
under normal circumstances are rapidly eliminated from the circulation by 
phagocytic cells of the spleen. 
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Figure 25 Immune complexes 
Immune complexes consist of an antigen, an antigen-specific antibody and usually 
complement components as well. 
In the presence of large quantities of auto-antigens and their specific auto-
antibodies small immune complexes are formed, which remain in circulation 
for an extended period of time. In addition, small immune complexes have 
access even to the smallest blood vessels including capillaries of the skin, the 
glomeruli of the kidney or they can accumulate in the joints as well. Immune 
complexes stuck in small vessels activate the complement system via the 
classical pathway at the site of deposition. Also phagocytic cells get activated, 
since both the complement fragments and the antibody molecules in immune 
complexes act as opsonins. This leads to inflammation and destruction of local 
self-tissues. These immune complex-mediated autoimmune diseases include 
vasculitis, glomerulonephritis or arthritis. Many pathogens (viral hepatitis, 
malaria) or environmental agents may trigger similar diseases (eg. „farmer’s 
lung” caused by a mold present on hay). Hypersensitivity reactions induced by 
immune complexes are called type III hypersensitivity reactions as well. 
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The mechanisms leading to the development of autoimmune diseases are often 
not clear. Multiple environmental and genetic factors may be responsible. 
Environmental factors may include pathogens, chemicals or even strong 
sunlight. Hormones may also play a role since most autoimmune diseases are 
more common in women than in men. The presence of certain MHC allotypes 
is also associated with a higher risk of autoimmune disease development.  
Immunodeficiencies 
Immunodeficiency is a state when the immune response to all or to a selected 
set of pathogens is insufficient, causing severe, recurrent infections or death. 
The so-called primary immunodeficiencies are caused by inherited genetic 
defects deleting essential components (cells or regulatory mechanisms) of the 
immune system. Acquired immunodeficiencies on the other hand are caused 
by environmental factors including toxic chemicals, chemotherapy or 
immunosuppressive drugs used at organ transplantations to impede 
transplant rejection.  
Transient immunodeficiency may develop after viral infections, for example 
measles, influenza, Epstein-Barr virus-induced mononucleosis. Some surgical 
procedures, malnutrition, smoking and stress, even transfusion with white 
blood cell-containing blood may cause temporary immunosuppression. 
There are over 200 primary immunodeficiency syndromes. Some babies are 
born without functional B cells and thus produce minimal or no antibodies, or 
when they have a defect in class switching, they produce only IgM antibodies. 
The lack of T cells causes an even more severe immune defect, as in the 
absence of T cells most B cell functions are also hampered. Therefore, in the 
absence of T cells, a combined, fatal immunodeficiency called severe 
combined immunodeficiency or SCID develops.  
The acquired immune deficiency syndrome, or AIDS is an immunodeficiency 
caused by the human immunodeficiency virus HIV. This retrovirus infects the 
T-helper cells and monocyte-derived macrophages bearing CD4 surface 
molecules. The virus is integrated, in the form of DNA into the human genome, 
where it may remain silent and hidden from the immune system for a long time. 
However, sooner or later the virus destroys the infected cell. As the number of 
the helper T cells in HIV-positive individuals is reduced, the patients gradually 
loose immune competence leading to the appearance of opportunistic 
infections (infections with organisms that are normally not pathogenic in 
immunocompetent individuals) or to development of cancer. This stage of the 




adaptive immunity Acquired / learnt immunity. A highly specific 
and efficient immune response, emerging after birth that uses 
antigen-specific receptors and antibody molecules. Capable 
of developing long-lasting immunological memory. 
adjuvant a substance mixed up with an immunogen in order to 
generate a more intense immune response 
anaphylatoxin Small cleavage products of some complement components, 
that can cause intense inflammatory reactions (even 
anaphylactic reaction). 
anaphylaxis anaphylactic shock/ systemic anaphylaxis Serious, systemic 
allergic reaction. 
anergy Functional unresponsiveness. Generally, naïve lymphocytes 
become anergic, if they react with an antigen without 
costimulation. 
antibody Glycoproteins produced by B cells. They bind appropriate 
antigens with high affinity and specificity. 
antigen Those molecules that can be recognized by antigen receptors 
and thus any material, that triggers a specific response from 
the immune system, either tolerance or a destructive immune 
response.  
antigenic determinant See epitope! 
antigen presenting cell or APC. A cell that processes extracellular 
or intracellular material and displays it in a form “visible” 
/detectable by T-lymphocytes. T cells can only recognize 
antigens that are processed and presented by antigen 
presenting cells as a peptide in complex with an MHC 
molecule. Nearly every cell in the body expresses MHC I 
molecules, thus can be regarded as APC. The professional 
antigen presenting cells express both MHC I, and MHC II 
molecules. 
antigen receptor A receptor expressed by B and T lymphocytes that 
recognizes native or processed antigens with high 
specificity.  
apoptosis Programmed or induced cell death. The „suicide” of the cell.  
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autocrine effect An effect of a hormone or other chemical substance acting 
on the cell by which the substance was produced. 
autoimmunity A self-reactive state of the adaptive immune system, when 
adaptive immune cells attack self-structures (self-antigens). 
BCR B cell receptor. The antigen receptor complex of the B cell. 
B cell See B lymphocyte 
B lymphocyte A cell type expressing antigen receptors that resemble an 
antibody. Precursors of plasma cells which produce large 
amounts of antibody. 
CD, CD nomenclature, CD molecules, CD antigens Cluster of 
Differentiation. Each cell type or the differentiation state of 
a lineage can be identified by the set of these cell-surface 
expressed molecules. These molecules were found and 
identified using specific antibodies. They are numbered by 
an international committee, usually following the order of 
their discovery. For example: functionally distinct T cell 
populations are the CD8 bearing cytotoxic and the CD4 
bearing helper T cells. 
cellular immune response Immune response mediated by different 
immunocytes (e.g.: cellular cytotoxicity mediated by 
cytotoxic T or NK cells, or phagocytosis by macrophages) 
chaperon A helper protein that facilitates other protein’s folding, 
transport etc. 
chemokine Cytokine that induces guided migration (chemotaxis) of 
cells. 
chemotactic factor Any soluble factor with a chemotactic effect. 
They may not be produced directly by cells. For example 
complement protein’s cleavage products are like this. 
complement receptors Receptors that can recognize some cleaved, 
activated, molecules of the complement system. 
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complement system Approximately 30 proteins found in the plasma, 
classified as part of the innate humoral immune response. 
Many of these proteins are proenzymes, others are able to 
recognize PAMPs. During their activation these proteins are 
able to activate each other in a proteolytic cascade reaction. 
Some cleavage products of the complement molecules can 
function as opsonins. They can induce inflammation others 
are able to destroy the activating pathogens directly. 
cross presentation Presentation of exogenous antigen on MHC I 
molecules. Dendritic cells are capable of this process. 
CTL Cytotoxic T Lymphocyte 
cytokine A soluble, hormone like messenger molecule produced by 
cells. It can influence the function of cells that express the 
cytokine-specific receptor. 
cytotoxicity Ability to kill cells. Many cells and humoral elements of the 
immune system are able to perform this function. It can be 
directed against free or engulfed pathogens. In a diseased 
state, it may be used against the organism’s own cells. 
DAMP Danger (damage) associated molecular pattern. A molecular 
pattern that signals danger or damage. 
dendritic cells A group of a phagocytic cells with typical dendritic structure. 
They act as professional antigen presenting cells. These cells 
have a critical role in activation of naïve T cells. 
domain Structural and/ or functional unit of protein molecules. 
Domains are frequently encoded by independent exons. 
endocrine effect An effect induced far away from the effector cell (usually 
delivered by blood circulation to anywhere in the body).  
endogenous Originates from within (of an organism, tissue, cell)  
epithelial cells Cells separating the body from the environment, linening and 
protecting internal, external surfaces of our body (skin, 
intestines, respiratory system, urinary tract) 
epitope or antigen determinant. The part of the antigen that is in 
physical contact with the antigen receptor, or the antibody. 
exogenous Originates from outside (of an organism, tissue, cell) 
extracellular Something that happens or exists outside the cell. 
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Fc region The region of the antibody, that is similar to a fragment 
formed during limited enzymatic cleavage of an antibody. It 
consists of disulphide linked constant domains of the heavy 
chains. Intact immunoglobulins have different effector 
functions, thanks to this region, e.g. by Fc receptor binding. 
Fc receptor A receptor, that is able to recognize the Fc region of an 
antibody. Fc receptors cannot recognize the variable region 
of the antibody, only the heavy-chains’ constant domains. 
glycoprotein Protein post-translationally modified by covalent attachment 
of oligosaccharide chains to the polypeptide chain. 
granulocytes A group of polymorphonuclear myeloid cells, with similar 
appearance under the light microscope: They have granules 
in their cytoplasm and a lobed nucleus. Neutrophil, 
eosinophil and basophil granulocytes belong in this group, 
based on their granular content. 
granzyme A protease produced by cytotoxic cells. In the target cell it 
induces cell death by apoptosis. . 
 
hematopoietic stem cell Undifferentiated cell type, with the capacity of 
self-renewal. Precursors of all cellular components of the 
blood. 
HLA Human Leukocyte Antigen, an alternative name for the 
human MHC-encoded genes. There are 3 classical human 
MHC I molecule coding genes, the HLA-A, HLA-B and 
HLA-C genes. The HLA-DP, HLA, DQ and HLA-DR gene 
regions are responsible for the coding of the classical human 
MHC II molecules. 
humoral immune response  Immune response delivered by 
soluble component of the immune system (e.g. antibodies, 
antimicrobial peptides or complement proteins). 
immune complex   The complex of antigens with 
bound antigen specific antibodies which usually includes 
bound complement proteins 
innate immunity The immunity one is born with. Its activation is based on 
recognition of PAMPs and DAMPs, (pathogen- or danger 
associated molecular patterns). Also called natural 
immunity. 
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interleukin Cytokines produced by leukocytes 
interferon Cytokines with antiviral activity. They are important in 
antiviral immune responses 
intracellular Something existing or happening inside the cell. 
invariant chain (Ii) The invariant chain participates in the maturation 
of the MHC II molecules. Binding to the MHC II molecule 
in the endoplasmic reticulum (ER), its main role is to inhibit 
binding of endogenous peptides in the ER to the MHC II  
isotype (of an antibody) Antibodies can be classified into isotypes or 
classes based on differences in their constant domains. 
Human antibodies based on their heavy chain’s constant 
region can be classified into 5 main groups (IgM, IgD, IgG, 
IgA, IgE). Based on their light chains, they are divided into 
two groups (kappa and lambda). Different antibody (heavy 
chain) isotypes can induce distinct effector functions with 
different efficiency. Subclasses are called isotypes as well. 
leukocyte White blood cells. Granulocytes, monocytes, macrophages, 
dendritic cells, NK cells, mast cells, T and B cells belong 
here. 
lymphocyte White blood cell group based on simple microscopic 
similarities: cells of this group have relatively large nucleus, 
and minimal cytoplasm. Leukocytes with different functions 
that belong to the lymphoid lineage. The adaptive B-, T 
lymphocytes and the innate NK cells belong in this group. 
LPS, lipopolysaccharide (also called endotoxin) Oligo- or 
polysaccharides covalently coupled to lipid molecules, 
taking part in the formation of the outer membrane of gram 
negative bacteria. 
macrophage Monocyte derived large cells, very effective in phagocytosis 
of larger particles. Different types of macrophages play a 
role in inflammatory processes and in tissue regeneration. 
They can also function as professional antigen presenting 
cells. 
mast cell A cell type specialized in the destruction of single cells or 
multicellular parasites. Compounds stored in its granules are 
effective against eukaryotic parasites. They play a key role 
in some inflammatory and allergic reactions. 
 80 
MHC Major Histocompatibility Complex. A chromosomal region 
encoding proteins with important role in antigen 
presentation. Some proteins expressed by the MHC locus – 
also called shortly MHC molecules– are expressed on the 
surface of APCs where they present peptides to the T cells. 
monocyte A leucocyte that belongs to the myeloid lineage. They are 
larger than lymphocytes with a typical „bean„ shaped 
nucleus circulating in blood. They are the precursors of 
macrophages. 
NK cell Natural Killer cell. An innate lymphocyte that can kill 
tumour cells or cells infected with pathogens. 
opsonin Molecules used for opsonization. These can be antibodies, 
cleaved complement proteins or other antimicrobial proteins 
for example acute phase proteins produced by the liver. 
opsonization The marking of a pathogen or antigen, so effector 
mechanisms of the immune system’s can be delivered more 
efficiently. Opsonized structures can be engulfed quicker or 
they can activate the complement system. 
PAMP Pathogen-associated molecular pattern, for example: 
bacterial lipopolysaccharide, flagellin, viral double stranded 
RNA. 
paracrine effect an effect, influencing cellular functions in the vicinity of the 
producing cell.  
pathogen Any agent causing a disease. It can be a single-cell or 
multicellular organism. Prokaryotic, eukaryotic, or virus. 
peptide A polymer of a few amino acids. 
perforin A cytotoxic protein produced by killer lymphocytes 
(cytotoxic T lymphocytes, NK cells). Its polymerized 
product forms a pore within the membrane of the target cell. 
plasma cell Antibody producing cells that differentiate from B cells. 
primary immune response The adaptive immune system’s that is generated 
at the first encounter with an antigen or a pathogen. The 
process that leads to activation of naïve lymphocytes. 
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primary lymphoid organ Organs where the immune cells develop from 
undifferentiated precursors. Two organs should be 
mentioned as primary lymphoid organ: the red bone marrow 
and the thymus. 
proenzyme Or zymogen. An inactive enzyme or enzyme precursor that 
must be activated by a biochemical process to perform its 
function. In case of some complement, limited proteolysis of 
zymogens is required for the activation of the subsequent 
component of the cascade.  
proliferation serial cell divisions 
professional antigen presenting cell. Professional APC.  
Antigen presenting cells are able to activate naïve T cells. 
Unlike other cells, these cells express MHC II molecules, by 
which they can present antigen derived peptides to helper T 
cells. Professional APCs are dendritic cells, macrophages 
and B cells. 
proteasome Large enzyme complex in the cell, with a cylindrical shape. 
It’s present in each eukaryotic cell and in some bacteria. It 
has role in the breakdown of unnecessary proteins. It 
produces peptides those are presented by MHC I molecules. 
protein A polymer molecule made of amino acids, many of these 
polymers have stable secondary and tertiary structure. 
PRR Pattern recognition receptor  
secondary lymphoid organ The sites where adaptive immune responses are 
initiated. The encounter with antigen, the activation and 
differentiation of the naïve cells of adaptive immunity occurs 
here. 
soluble not solid, or cell surface bound (for example: the antibody is 
the soluble form of B cell receptor) 
stem cell Undifferentiated cell type that has self- renewing capacity. It 
can differentiate into a wide variety of cell types. 
T cell See T lymphocyte. 
T lymphocyte Lymphocyte that bares TCR antigen receptor. It has multiple 
functionally distinct types. Some can destroy infected cells, 
others influence the outcome of the immune response, or 
makes it more efficient  
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TCR T cell receptor. T cell’s antigen receptor complex 
TNF  tumour necrosis factor. Cytokine, produced by many cell 
types of the immune system. It has wide range of effects. 
This cytokine has more types, however, unless indicated 
otherwise, TNF means TNF-α. It can be produced during 
inflammatory processes. It can have cell-activating, or cell-
killing effect 
Toxin Poison. Toxins of immunologically distant organisms. 
Bacteria, produce toxins that behave as antigens. They can 
induce antibody production. 
zymogen See proenzyme 
 
